Retour

Explorez tous les épisodes du podcast PICU Doc On Call

Plongez dans la liste complète des épisodes de PICU Doc On Call. Chaque épisode est catalogué accompagné de descriptions détaillées, ce qui facilite la recherche et l'exploration de sujets spécifiques. Suivez tous les épisodes de votre podcast préféré et ne manquez aucun contenu pertinent.

Rows per page:

1–50 of 131

TitreDateDurée
Pediatric Critical Care Board Review Part 225 Oct 202600:35:45

A child with DKA develops a worsening headache, altered mental status, and bradycardia: the hosts explain why suspected cerebral injury should be treated before imaging. Dr. Pradip Kamat and Rahul Damania bring that same bedside focus to a rapid-fire pediatric critical care board review, covering medication dosing, kidney and electrolyte emergencies, endocrine crises, and liver failure. Along the way, they explain why a normal anion gap can hide acidosis when albumin is low, how a dangerously wide QRS in hyperkalemia changes the treatment order, and why acute liver failure can meet criteria even without obvious encephalopathy. Short cases, clear answers, and practical physiology make this a focused review for the PICU and the boards.

Show Highlights:

  • Medication dosing in acute kidney injury, including loading versus maintenance doses
  • Phenytoin’s nonlinear kinetics and extended-infusion beta-lactam antibiotics
  • Kidney and electrolyte disorders, including metabolic alkalosis, hypokalemia, and anion-gap interpretation
  • Hyponatremia, sodium correction, cerebral salt wasting, and pseudohyponatremia
  • Hyperkalemia management, rhabdomyolysis, and kidney replacement therapy
  • Diabetic ketoacidosis and suspected cerebral injury
  • Endocrine emergencies, including adrenal crisis, thyroid storm, and hypoglycemia
  • Metabolic disorders, including urea cycle disorders and hyperammonemia
  • Pediatric acute liver failure and lactulose’s role in ammonia management
  • Nutrition assessment and the effects of inflammation on albumin and prealbumin

References:

Medication questions

  • FDA Dilantin prescribing information: saturable metabolism and interpretation of unbound phenytoin in hypoalbuminemia and renal/hepatic disease.
  • Fuhrman & Zimmerman’s Pediatric Critical Care, 6th edition: background pharmacology, renal physiology, acid–base, and endocrine chapters.

Electrolytes and kidney support


Endocrine and metabolic questions

  • Glaser N, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022;23:835–856. Full guideline.
  • Kuppermann N, et al. Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis. N Engl J Med. 2018;378:2275–2287. The trial did not find significant neurologic outcome differences among the fluid regimens studied.
  • American Thyroid Association: Hyperthyroidism in Children and Adolescents; 2016 ATA guideline.
  • Additional background and references are provided in the linked hypoglycemia and hyperammonemia episodes.

Liver and nutrition questions

  • Squires JE, et al. NASPGHAN Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure. J Pediatr Gastroenterol Nutr. 2022;74:138–158. Full position paper.
  • Squires RH, et al. Intravenous N-acetylcysteine in Pediatric Patients with Non-Acetaminophen Acute Liver Failure. Hepatology. 2013;57:1542–1549.
  • Evans DC, et al. The Use of Visceral Proteins as Nutrition Markers: An ASPEN Position Paper. Nutr Clin Pract. 2021;36:22–28. PubMed.

Board review scope


Pediatric Critical Care Board Review Part 120 Oct 202600:47:06

A hemoglobin increase from 8 to 12 can boost oxygen delivery far more than raising oxygen saturation from 88% to 98%—but that doesn’t mean transfusing every child to 12 is the right call. In part one of this pediatric Critical Care Board Review, Dr. Pradip Kamat, Dr. Rahul Damania, and Dr.Monica Gray connect high-yield equations to urgent bedside decisions: when intubation may improve a failing heart, why a normal blood gas can hide impending respiratory failure, and how hyperventilation can lower intracranial pressure while dangerously reducing cerebral blood flow. They also tackle ventilator waveforms, ECMO anticoagulation, transfusion complications, and the test-taking strategies that make physiology easier to apply under pressure.

Show Highlights:

  • Board-preparation strategies and physiology-based clinical reasoning
  • Oxygen delivery, oxygen content, and hemoglobin’s role
  • Cardiac shunts, Qp:Qs, and duct-dependent congenital heart disease
  • Cardiopulmonary interactions, ventilation, and hemodynamics
  • Rhythm disturbances, CPR, and ECMO perfusion concepts
  • Gas exchange, alveolar gas equation, and oxygenation indices
  • Ventilator pressures, waveforms, time constants, and dead space
  • Cerebral perfusion, traumatic brain injury, and neurologic emergencies
  • Neuromuscular respiratory failure, seizures, and brain death assessment
  • Anticoagulation, transfusion complications, sickle cell disease, and other hematologic emergencies

Resources:

  • American Board of Pediatrics. Pediatric Critical Care Medicine Content Outline. https://www.abp.org/sites/abp/files/outline-critical-care-updated.pdf
  • Fuhrman & Zimmerman’s Pediatric Critical Care, 6th ed. (Elsevier) — chapters on cardiopulmonary interactions, respiratory physiology and mechanical ventilation, neurocritical care, and hematologic emergencies. (add chapter numbers)
  • Emeriaud G, et al. Executive Summary of the Second International Guidelines for the Diagnosis and Management of Pediatric Acute Respiratory Distress Syndrome (PALICC-2). Pediatr Crit Care Med. 2023;24(2):143–168.
  • Greer DM, et al. Pediatric and Adult Brain Death/Death by Neurologic Criteria Determination: Consensus Guideline. Neurology. 2023.
  • Kochanek PM, et al. Guidelines for the Management of Pediatric Severe Traumatic Brain Injury, Third Edition. Pediatr Crit Care Med. 2019;20(3S Suppl 1):S1–S82.
  • American Heart Association & American Academy of Pediatrics. 2025 Pediatric Advanced Life Support Guidelines. https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines/pediatric-advanced-life-support
  • Kapur J, et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus (ESETT). N Engl J Med. 2019;381:2103–2113.
  • Lacroix J, et al. Transfusion Strategies for Patients in Pediatric Intensive Care Units (TRIPICU). N Engl J Med. 2007;356:1609–1619.
  • Valentine SL, et al. Consensus Recommendations for RBC Transfusion Practice in Critically Ill Children (TAXI). Pediatr Crit Care Med. 2018;19(9):884–898.

128: Beta Blocker Toxicity in the PICU: Slow Heart, Fading Mind, and Falling Sugar06 Sep 202600:23:03

In this episode of *PICU Doc on Call*, Drs. Pradip Kamat and Rahul Damania dive into the topic of beta-blocker toxicity. They walk through a case of a 15-year-old who comes in with bradycardia, hypotension, hypoglycemia, and altered mental status after an intentional ingestion. Using a board-style question, they break down how to tell the difference between beta-blocker and calcium channel blocker poisoning and review key points about cardiac physiology and receptor signaling.

Drs. Kamat and Damania discuss management strategies, including glucagon, high-dose insulin therapy, vasopressors, calcium, and ECMO as a last resort. They also spend some time focusing on specific agents like propranolol and sotalol, highlighting what makes their toxicologic profiles unique. This is a high-yield episode packed with pearls for pediatric intensivists!

Show Highlights:

  • Clinical case of a 15-year-old patient with bradycardia and hypotension due to intentional drug ingestion
  • Beta-blocker toxicity and its clinical features
  • Differentiation between beta-blocker and calcium channel blocker toxicity
  • Key physiological concepts related to cardiac action potentials and beta receptor function
  • Clinical presentation and diagnostic workup for beta-blocker toxicity
  • Management strategies for beta blocker overdose, including airway control and fluid resuscitation
  • Specific toxicologic profiles of common beta-blockers (e.g., propranolol, sotalol, metoprolol)
  • Importance of recognizing hypoglycemia and CNS effects in beta-blocker toxicity
  • Summary of critical management steps and take-home points for pediatric intensivists
  • Encouragement for further learning and engagement on related topics

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter 126. Toxidromes and their treatment. Joshi P. Pages 1504-1505
  • Reference 1: Rogers textbook of Pediatric Intensive Care: Chapter 36: Poisoning. Nares M, Jeyapalan A, Weisman R: pages 525-543
  • Reference 2: Lavonas EJ, Akpunonu PD, Arens AM, Babu KM, Cao D, Hoffman RS, Hoyte CO, Mazer-Amirshahi ME, Stolbach A, St-Onge M, Thompson TM, Wang GS, Hoover AV, Drennan IR; American Heart Association. 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2023 Oct 17;148(16):e149-e184. doi: 10.1161/CIR.0000000000001161. Epub 2023 Sep 18. PMID: 37721023.
  • Suarez F, Koyfman A, Long B. Pearls and Pitfalls for the Emergency Clinician: Beta Blocker and Calcium Channel Blocker Toxicity. J Emerg Med. 2026 May;84:1-11. doi: 10.1016/j.jemermed.2026.01.021. Epub 2026 Jan 27. PMID: 41833262.

Hello From the Otherside! Transport Calls23 Aug 202600:21:10

In this episode of PICU Doc on Call, third-year PICU fellow Dr. Alexandria Edwards joins Drs. Pradip Kamat, Monica Gray, and Rahul Damania for a quick and practical dive into pediatric transport medicine. Dr. Edwards walks us through her go-to framework for handling transport calls, highlighting the importance of systematically checking vitals, respiratory support, the physical exam, labs, and any interventions. The team uses a real-life case of a 12-year-old with severe status asthmaticus to talk through how to pick the right transport mode, why it’s best to avoid intubation if you can, and how to make sure you’re on the same page with the ICU team before the patient arrives. The main message? Build a solid, structured approach to transport calls and practice it every time.

Show Highlights:

  • Overview of pediatric intensive care unit (PICU) fellowship and training
  • Importance of transport medicine in the PICU setting
  • Framework for handling transport calls effectively
  • Key considerations for assessing patient stability during transport
  • Importance of vital signs and current patient status in decision-making
  • Strategies for communicating with referring providers
  • Discussion of a specific case involving a pediatric patient with asthma exacerbation
  • Decision-making process for mode of transport (ground vs. air)
  • Role of critical care transport teams in patient transfer
  • Tips for preparing the receiving ICU team for incoming patients

We welcome your feedback and reviews. Please visit our website at https://picudoconcall.org/, where you can find our episodes.

Metformin Overdose in the Pediatric ICU | A Case of Low pH09 Aug 202600:20:28

In this episode, Drs. Pradip Kamat, Monica Gray, and Rahul Damania talk through a heartbreaking case involving a 14-year-old girl with a history of psychiatric illness who intentionally took 45 tablets of metformin and empagliflozin. Things went downhill quickly—she developed severe lactic acidosis, hypoglycemia, acute kidney injury, and eventually suffered a cardiac arrest that required ECMO and continuous dialysis. Sadly, even with the most aggressive care, she didn’t make it. The doctors walk listeners through the pharmacology and toxicity of metformin and empagliflozin, discuss how these drugs can cause harm, and share key management strategies. They really stress the importance of early recognition, using extracorporeal therapies, and working as a multidisciplinary team when dealing with severe pediatric overdoses of antidiabetic medications.

Show Highlights:

  • Case study of a 14-year-old girl with intentional ingestion of an oral antidiabetic agent
  • Presentation of severe lactic acidosis, hypoglycemia, acute kidney injury, and cardiac arrest
  • Discussion of the pharmacology and toxicology of metformin and empagliflozin
  • Mechanisms of metformin toxicity and its effects on metabolic processes
  • Differentiation between types of lactic acidosis related to metformin
  • Importance of early recognition and management of metformin toxicity
  • Supportive care strategies for managing severe metformin overdose
  • Role of extracorporeal therapies, including ECMO and dialysis, in treatment
  • Multidisciplinary approach involving intensivists, nephrologists, and toxicologists
  • Clinical implications and outcomes of severe metformin toxicity in pediatric patients

Resources:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter: Nothing found
  • Reference 1: Noites I, Figueiredo M, Shchomak Z, Boto L, Camilo C. Fatal Pediatric Metformin-Associated Lactic Acidosis: When Severity Goes Unnoticed. Cureus. 2026 Feb 16;18(2):e103719.
  • Reference 2: Bebarta VS, Pead J, Varney SM. Lacticemia After Acute Overdose of Metformin in an Adolescent Managed Without Intravenous Sodium Bicarbonate or Extracorporeal Therapy. Pediatr Emerg Care. 2015 Aug;31(8):589-90.

Capnography in the PICU | Take My Breath Away26 Jul 202600:21:35

In this episode of *Pediatric Critical Care Insights*, Dr. Monica Gray and Dr. Pradip Kamat chat about how capnography, specifically end-tidal CO2 monitoring, is used in the pediatric ICU. They walk through a real-life case of a 9-year-old with respiratory failure from influenza A, showing how ETCO2 monitoring helps confirm endotracheal tube placement, guides ventilation, spots cardiac arrest, and even helps assess the quality of CPR. Along the way, they break down how to interpret capnography waveforms, discuss different types of devices, and explain the key physiological concepts. The episode is packed with practical, bedside tips for intensivists caring for critically ill kids.

Show Highlights:

  • Importance of capnography (end-tidal CO2 monitoring) in the pediatric intensive care unit (PICU)
  • Clinical case study of a 9-year-old boy with respiratory failure due to influenza A
  • Use of capnography for confirming endotracheal tube placement and assessing ventilation status
  • Detection of cardiac arrest and guidance for CPR quality through ETCO2 monitoring
  • Overview of capnography physics and physiology, including terminology distinctions
  • Types of capnography: mainstream vs. sidestream, and their applications in pediatric patients
  • Assumptions for accurate ETCO2 approximation of arterial CO2 and conditions affecting this relationship
  • Analysis of capnography waveform phases and their clinical significance
  • Prognostic value of ETCO2 during cardiac arrest and its correlation with patient outcomes
  • Practical applications of ETCO2 monitoring in critical care, focusing on airway, breathing, and circulation management

References:

  1. Noninvasive respiratory monitoring and assessment of gas exchange. David F. Butler; Kenneth A. Schenkman. Fuhrman and Zimmerman's Pediatric Critical Care, 43, 483-491.e3
  2. Humphreys S, Schibler A, von Ungern-Sternberg BS. Carbon dioxide monitoring in children—A narrative review of physiology, value, and pitfalls in clinical practice. Pediatr Anaesth. 2021;31:839–845. https://doi.org/10.1111/pan.14208
  3. Lasa JJ, Dhillon GS, Duff JP, et al. Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Pediatrics. 2026;157(1):e2025074351
  4. O'Flaherty. Capnography: principles and practice. London: BMJ Publishing Group; 1994.
  5. Aminiahidashti H, Shafiee S, Zamani Kiasari A, Sazgar M. Applications of End-Tidal Carbon Dioxide (ETCO2) Monitoring in Emergency Department; a Narrative Review. Emerg (Tehran). 2018;6(1):e5. Epub 2018 Jan 15. PMID: 29503830; PMCID: PMC5827051.

Start Off Strong: Tips and Tricks for 1st-year PICU Fellows12 Jul 202600:18:16

In this special episode of *PICU Doc on Call*, hosts Dr. Monica Gray and Dr. Rahul Damania welcome new pediatric critical care fellows across the U.S. with practical advice for day one of fellowship. Joined by third-year PICU fellow Dr. Alexandra Bryant, the episode covers three key areas: navigating PICU logistics, protecting mental health, and managing the overwhelming volume of critical care knowledge. Dr. Bryant shares candid insights from her own training journey, offering actionable strategies for success. The hosts remind listeners that fellowship is a learning process and that new fellows can make a meaningful impact.

Show Highlights

  • Introduction to pediatric critical care fellowship for new fellows and learners
  • Key insights and advice for first-year fellows in pediatric intensive care
  • Importance of understanding logistics in the PICU environment
  • Strategies for effective communication and collaboration within the PICU team
  • Managing mental health and self-care during fellowship
  • Techniques for absorbing and retaining vast knowledge in pediatric critical care
  • Recommendations for organizing study materials and resources
  • Emphasis on lifelong learning and accessing information effectively
  • Practical tips for time management and responsibility organization
  • Suggested resources for mindfulness and emotional support in medical training

Resource:

PICU Doc on Call Episode 31

Time Constants in the PICU | PICU Doc on Call Shorts05 Jul 202600:18:58

In this episode of *PICU Doc on Call Shorts*, pediatric ICU physicians Dr. Pradip Kamat and Dr. Rahul Damania discuss respiratory time constants and their clinical relevance in pediatric critical care. Using a case of a six-year-old with near-fatal status asthmaticus on mechanical ventilation, they explain how prolonged time constants from high airway resistance cause air trapping, dynamic hyperinflation, and intrinsic PEEP. They emphasize recognizing these issues through ventilator waveforms and highlight that increasing respiratory rate can worsen hypercapnia in obstructive disease. Key management strategies include reducing respiratory rate, extending expiratory time, and accepting permissive hypercapnia to ensure hemodynamic stability.

Show Highlights

  • Respiratory time constants and their clinical significance in pediatric patients
  • Case study of a six-year-old boy with near-fatal status asthmaticus
  • Management of severe obstructive respiratory failure in pediatric patients
  • Understanding airway resistance and lung compliance in relation to time constants
  • Impact of ventilator settings on patient outcomes, including air trapping and intrinsic PEEP
  • Importance of adequate expiratory time to prevent dynamic hyperinflation
  • Recognizing signs of inadequate expiratory time in mechanically ventilated patients
  • Strategies for managing hypercapnia and optimizing ventilator settings
  • Differences in time constants related to various pediatric respiratory conditions
  • Key takeaways for pediatric critical care practice and ventilator management

References
  1. Depta F, Kallet RH, Gentile MA, Kassis EN. Expiratory time constants in mechanically ventilated patients: rethinking the old concept — a narrative review. Intensive Care Medicine Experimental. 2025;13:40. The review summarizes the definition of expiratory time constant, the relationship to resistance and compliance, the 63/86/95/98/99% rule, and clinical applications in obstructive and acute lung injury states.
  2. Depta F, et al. Six methods to determine expiratory time constants in mechanically ventilated patients: a prospective observational physiology study. Intensive Care Medicine Experimental. 2024. This study describes expiratory time constant as a parameter that can guide respiratory rate and I:E adjustment to support complete exhalation.
  3. Alibrahim O, Rehder KJ, Miller AG, Rotta AT. Mechanical Ventilation and Respiratory Support in the Pediatric Intensive Care Unit. Pediatric Clinics of North America. 2022;69(3):587–605. This pediatric review specifically discusses passive exhalation, the expiratory time constant, and why asthma and bronchiolitis require longer expiratory times to avoid gas trapping.
  4. Arnal JM. Monitoring respiratory mechanics in mechanically ventilated patients. Hamilton Medical Knowledge Base. This source provides a practical bedside description of time constants, waveform-based respiratory mechanics, and typical RCexp ranges, while emphasizing dependence on resistance and compliance.
  5. Emeriaud G, López-Fernández YM, Iyer NP, et al.; PALICC-2 Group; PALISI Network. Executive summary of the second international guidelines for the diagnosis and management of pediatric ARDS. Pediatric Critical Care Medicine. 2023;24(2):143–168. The PALICC-2 guideline framework supports lung-protective ventilation in PARDS, including attention to tidal volume, PEEP, plateau pressure, and driving pressure.

Sweet Dreams: Procedural Sedation in the PICU21 Jun 202600:33:53

In this episode of PICU Doc on Call, hosts Dr. Monica Gray and Dr. Pradip Kamat explore procedural sedation in the pediatric ICU. They cover sedation levels, pre-screening, risk stratification using ASA classifications, and medication selection tailored to each patient's hemodynamic and respiratory status. Through real-world case discussions involving respiratory failure, septic shock, and acute neurological decline, they highlight the importance of end-tidal CO2 monitoring and early adverse event recognition. Key takeaways include avoiding the term "conscious sedation," preparing rescue plans, and prioritizing patient safety through careful assessment and monitoring.

Show Highlights:

  • Definitions and levels of sedation (minimal, moderate, deep sedation, and general anesthesia)
  • Importance of terminology in procedural sedation
  • Monitoring sedation levels using scales like the Richmond Agitation-Sedation Scale (RASS)
  • Pre-screening and risk stratification considerations for pediatric patients
  • ASA physical status classification system for assessing patient risk
  • Unique challenges of procedural sedation in critically ill children
  • Adverse events associated with pediatric procedural sedation, particularly respiratory complications
  • Management strategies for specific cases requiring sedation (e.g., respiratory failure, septic shock)
  • Importance of end-tidal CO2 monitoring during sedation
  • Key takeaways for safe sedation practices in the pediatric ICU setting

References:

  1. Nir Atlas; Rahul C. Damania; Pradip P. Kamat In Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter 135, 1624-1628
  2. Statement on Continuum of Depth of Sedation: Definition of General Anesthesia and Levels of Sedation/Analgesia by Committee on Quality Management and Departmental Administration. Last Amended: October 23, 2024.
  3. Coté CJ, Wilson S; AMERICAN ACADEMY OF PEDIATRICS; AMERICAN ACADEMY OF PEDIATRIC DENTISTRY. Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures. Pediatrics. 2019 Jun;143(6):e20191000. doi: 10.1542/peds.2019-1000. PMID: 31138666.x
  4. Krauss B, Green SM. Procedural sedation and analgesia in children. Lancet. 2006 Mar 4;367(9512):766-80. doi: 10.1016/S0140-6736(06)68230-5. PMID: 16517277.
  5. Sharif S, Kang J, Sadeghirad B, Rizvi F, Forestell B, Greer A, Hewitt M, Fernando SM, Mehta S, Eltorki M, Siemieniuk R, Duffett M, Bhatt M, Burry L, Perry JJ, Petrosoniak A, Pandharipande P, Welsford M, Rochwerg B. Pharmacological agents for procedural sedation and analgesia in the emergency department and intensive care unit: a systematic review and network meta-analysis of randomised trials. Br J Anaesth. 2024 Mar;132(3):491-506. doi: 10.1016/j.bja.2023.11.050. Epub 2024 Jan 6. PMID: 38185564.
  6. Smith, Heidi A. B. MD, MSCI (Chair)1,2; Besunder, James B. DO, FCCM3,4; Betters, Kristina A. MD1; Johnson, Peter N. PharmD, BCPS, BCPPS, FCCM, FPPA, FASHP5,6; Srinivasan, Vijay MBBS, MD, FCCM7,8; Stormorken, Anne MD9,10; Farrington, Elizabeth PharmD, FCCM11; Golianu, Brenda MD12,13; Godshall, Aaron J. MD14; Acinelli, Larkin CPNP-AC, ACHPN15; Almgren, Christina CPNP16; Bailey, Christine H. MD17; Boyd, Jenny M. MD18,19; Cisco, Michael J. MD20; Damian, Mihaela MD, MPH21,22; deAlmeida, Mary L. MD23,24; Fehr, James MD13,25; Fenton, Kimberly E. MD, FCCM14; Gilliland, Frances DNP, CPNP-AC/PC26,27; Grant, Mary Jo C. CPNP-AC, PhD, FAAN28; Howell, Joy MD29; Ruggles, Cassandra A. PharmD, BCCCP, BCPPS30; Simone, Shari DNP31,32; Su, Felice MD21,22; Sullivan, Janice E. MD33,34; Tegtmeyer, Ken MD, FAAP, FCCM35,36; Traube, Chani MD, FCCM29; Williams, Stacey CPNP-AC37; Berkenbosch, John W. MD, FAAP, FCCM (Chair)33,34. 2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility. Pediatric Critical Care Medicine 23(2):p e74-e110, February 2022. | DOI: 10.1097/PCC.0000000000002873
  7. Benzoni T, Agarwal A, Cascella M. Procedural Sedation. [Updated 2025 Mar 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551685/
  8. Kerson AG, DeMaria R, Mauer E, Joyce C, Gerber LM, Greenwald BM, Silver G, Traube C. Validity of the Richmond Agitation-Sedation Scale (RASS) in critically ill children. J Intensive Care. 2016 Oct 26;4:65. doi: 10.1186/s40560-016-0189-5. PMID: 27800163; PMCID: PMC5080705.
  9. Tel-Dan SF, Shavit D, Nates R, Samuel N, Shavit I. Emergency Physician-Administered Sedation for Thoracostomy in Children With Pleuropneumonia. Pediatr Emerg Care. 2021 Dec 1;37(12):e1209-e1212. doi: 10.1097/PEC.0000000000001975. PMID: 31929389.
  10. Cosgrove P, Krauss BS, Cravero JP, Fleegler EW. Predictors of Laryngospasm During 276,832 Episodes of Pediatric Procedural Sedation. Ann Emerg Med. 2022 Dec;80(6):485-496. doi: 10.1016/j.annemergmed.2022.05.002. Epub 2022 Jun 23. PMID: 35752522.
  11. Cravero JP, Blike GT, Beach M, Gallagher SM, Hertzog JH, Havidich JE, Gelman B; Pediatric Sedation Research Consortium. Incidence and nature of adverse events during pediatric sedation/anesthesia for procedures outside the operating room: report from the Pediatric Sedation Research Consortium. Pediatrics. 2006 Sep;118(3):1087-96. doi: 10.1542/peds.2006-0313. PMID: 16951002.

Pink Toes and Blue Brain on VA ECMO (North South Syndrome on ECMO)07 Jun 202600:24:00

In this episode of *PICU Doc on Call*, Dr. Monica Gray and Dr. Pradip Kamat are joined by fellow Dr. Hope Vancleve to discuss a complex case of a 12-year-old with MRSA septic shock requiring VA ECMO. The conversation covers sepsis-induced myocardial dysfunction, including its pathophysiology, diagnosis, and management. The hosts also explore differential hypoxia, or Harlequin syndrome, a serious VA ECMO complication causing upper body deoxygenation, and discuss monitoring strategies and circuit reconfiguration to prevent cerebral and myocardial ischemia.

Show Highlights:

  • Clinical case discussion of a 12-year-old male patient with MRSA septic shock.
  • Complications of sepsis, including sepsis-induced myocardial dysfunction and refractory shock.
  • Management strategies for septic shock, including antibiotic therapy and fluid resuscitation.
  • Use of venoarterial ECMO support in pediatric patients with severe cardiac dysfunction.
  • Pathophysiology of sepsis-induced myocardial dysfunction and its impact on cardiac function.
  • Differential hypoxia (North-South syndrome) in patients on femoral VA ECMO.
  • Diagnostic approaches for sepsis-induced myocardial dysfunction, including echocardiography and biomarkers.
  • Importance of monitoring and managing end-organ function in septic patients.
  • Strategies for addressing differential hypoxia in ECMO patients, including circuit reconfiguration.
  • Discussion of the risks and benefits of various ECMO configurations and management techniques.

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter
  • Reference 1: Torre DE, Pirri C. Harlequin Syndrome in Venoarterial ECMO and ECPELLA: When ECMO and Native or Impella Circulations Collide - A Comprehensive Review. Rev Cardiovasc Med. 2025 Aug 26;26(8):39992. doi: 10.31083/RCM39992. PMID: 40927093; PMCID: PMC12415751.
  • Reference 2 : Cove ME. Disrupting differential hypoxia in peripheral veno-arterial extracorporeal membrane oxygenation. Crit Care. 2015 Jul 22;19(1):280. doi: 10.1186/s13054-015-0997-3. PMID: 27391473; PMCID: PMC4511033.

Of Rats & Men: Approach to Coumadin Overdose in the PICU24 May 202600:20:39

In this episode of PICU Doc on Call, hosts Dr. Monica Gray and Dr. Pradip Kamat discuss a 15-year-old girl who attempted suicide by ingesting rat poison, acetaminophen, ibuprofen, and amlodipine. The episode focuses on long-acting anticoagulant rodenticides (LAARs), such as brodifacoum, which inhibit vitamin K epoxide reductase, causing delayed coagulopathy. Key topics include clinical presentation, diagnostic evaluation, and management, emphasizing vitamin K1 as the primary antidote and prothrombin complex concentrate or fresh-frozen plasma for major bleeding. The patient stabilized with aggressive supportive care, including vasoactive agents and NAC therapy, alongside psychiatric intervention. Listen to learn more!

Show Highlights

  • Clinical case of a 15-year-old girl who attempted suicide through polypharmacy ingestion
  • Ingestion of multiple substances, including chewable rat poison, acetaminophen, ibuprofen, and amlodipine
  • Discussion of toxicology related to long-acting anticoagulant rodenticides (LAARs) like brodifacoum
  • Symptoms and clinical presentation following acute ingestion, including metabolic acidosis and elevated lactate
  • Diagnostic evaluation and laboratory findings, including coagulation studies and liver function tests
  • Management strategies for LAAR poisoning, including the use of vitamin K and supportive care
  • Importance of monitoring for delayed coagulopathy and serial INR testing
  • Consideration of calcium channel blocker toxicity in the context of the patient's clinical instability
  • Overview of the mechanisms of action of LAARs and their impact on vitamin K-dependent clotting factors
  • Key take-home points regarding the recognition and management of rodenticide ingestion in pediatric patients

References

Reference: King N, Tran MH. Long-Acting Anticoagulant Rodenticide (Superwarfarin) Poisoning: A Review of Its Historical Development, Epidemiology, and Clinical Management. Transfus Med Rev. 2015 Oct;29(4):250-8.

Reference 2: Feinstein DL, Akpa BS, Ayee MA, et al. The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures. Ann N Y Acad Sci. 2016 Jun;1374(1):111-22.

Mind Your Scope: Bronchoscopy Pearls for the Pediatric Intensivist10 May 202600:16:10

In this episode of PICU Doc on Call, Dr. Monica Gray and Dr. Pradip Kamat chat about flexible fiberoptic bronchoscopy (FFB) in the pediatric ICU. They walk through a case involving an eight-year-old who’s dealing with respiratory failure after a stem cell transplant. Along the way, they talk about when and why you might use bronchoscopy both for diagnosis and treatment—plus how to approach sedation and what effects the procedure can have on the heart and lungs. They also dive into important topics like managing hypoxia, handling increased airway and pulmonary vascular resistance, and what to keep in mind if your patient has a traumatic brain injury. The episode wraps up with tips for managing fever after the procedure and a quick look at how rigid bronchoscopy compares.

Show Highlights:

  • Use of flexible fiberoptic bronchoscopy (FFB) in the pediatric ICU (PICU)
  • Indications for performing bronchoscopy (diagnostic and therapeutic)
  • Management of sedation and analgesia during bronchoscopy
  • Cardiovascular effects associated with bronchoscopy procedures
  • Respiratory effects and complications during bronchoscopy
  • Special considerations for bronchoscopy in patients with traumatic brain injury (TBI)
  • Post-procedure complications, including fever and its management
  • Overview of rigid bronchoscopy and its indications
  • Importance of understanding physiological changes during bronchoscopy
  • Educational focus on acute pediatric care for current and aspiring PICU interns

References:

Reference 1: Sachdev A, Chhawchharia R. Flexible Fiberoptic Bronchoscopy in Pediatric Practice. Indian Pediatr. 2019 Jul 15;56(7):587-593. PMID: 31333214.

Reference 2: Li SX, Tao XF, Wu HJ, Jin F, Zhu GH, Wang YS, Tang LF, Chen ZM, Wu L. Advances in pediatric flexible bronchoscopy. World J Pediatr. 2025 Oct;21(10):945-956. doi: 10.1007/s12519-025-00967-7. Epub 2025 Oct 4. PMID: 41045338; PMCID: PMC12578761.

Reference 3: Truitt BA, Kasi AS, Kamat PP, Fundora MP, Simon DM, Guglani L. Cryoextraction via flexible bronchoscopy in children with tracheobronchial obstruction. Pediatr Pulmonol. 2023 Sep;58(9):2527-2534. doi: 10.1002/ppul.26540. Epub 2023 Jun 23. PMID: 37350368.

Isoflurane in the PICU26 Apr 202600:12:10

In this episode of "PICU Doc on Call," Drs. Monica Gray and Pradip Kamat from Children's Healthcare of Atlanta dive into the use of inhaled anesthetics, especially isoflurane, in the pediatric ICU. We’re focusing on those tough cases: refractory status asthmaticus and status epilepticus.

We’ll chat about why isoflurane is our go-to over other agents like sevoflurane, desflurane, or nitrous oxide, and break down its bronchodilatory and anticonvulsant properties. We’ll also touch on important pharmacology concepts, such as MAC and the blood-gas partition coefficient, and discuss how we approach dosing and ventilator management when using isoflurane.

Of course, we’ll also discuss the potential adverse effects that can come with prolonged use, and why it’s important to stop other sedatives and beta-agonists once you start isoflurane. Join us as we walk through the practical aspects and pearls for using inhaled anesthetics in the PICU!

Show Highlights:

  • Use of inhaled anesthetics in pediatric intensive care units (PICU)
  • Focus on isoflurane for managing refractory status asthmaticus and status epilepticus
  • Comparison of inhaled anesthetic agents: isoflurane, sevoflurane, nitrous oxide, and desflurane
  • Importance of minimum alveolar concentration (MAC) and blood-gas partition coefficient in anesthetic pharmacodynamics
  • Mechanism of action of isoflurane in airway management and bronchodilation
  • Clinical administration techniques for isoflurane in critically ill children
  • Ventilator management principles for intubated children with status asthmaticus
  • Role of isoflurane in refractory and super-refractory status epilepticus
  • Potential adverse effects and considerations for prolonged isoflurane use
  • Summary of pharmacologic concepts essential for safe isoflurane therapy in pediatric patients

References:

  • Rogers Text Book of Pediatric Intensive Care: Chapter 47: Acute Severe Asthma. Stewart C, Brilli RJ. pages 763-775
  • Reference 1: Stetefeld HR, Schaal A, Scheibe F, Nichtweiß J, Lehmann F, Müller M, Gerner ST, Huttner HB, Luger S, Fuhrer H, Bösel J, Schönenberger S, Dimitriadis K, Neumann B, Fuchs K, Fink GR, Malter MP; IGNITE Study Group, with support from the German Neurocritical Care Society (DGNI). Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation. Neurocrit Care. 2021 Dec;35(3):631-639. doi: 10.1007/s12028-021-01250-z. Epub 2021 Jul 20. PMID: 34286464; PMCID: PMC8692280.
  • Reference 2: Zeiler FA, Zeiler KJ, Teitelbaum J, Gillman LM, West M. Modern inhalational anesthetics for refractory status epilepticus. Can J Neurol Sci. 2015 Mar;42(2):106-15. doi: 10.1017/cjn. 2014.121. Epub 2015 Jan 9. PMID: 25572922.
  • Reference 3: Werner HA. Status asthmaticus in children: a review. Chest. 2001 Jun;119(6):1913-29. doi: 10.1378/chest. 119.6.1913. PMID: 11399724.
  • Reference 4: Gill B, Bartock JL, Damuth E, Puri N, Green A. Case report: Isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation. Front Med (Lausanne). 2022 Nov 8;9:1051468. doi: 10.3389fmed. .2022.1051468. PMID: 36425104; PMCID: PMC9679515.

The Tylenol Trouble & the NAC comeback: Navigating Acetaminophen Toxicity in the PICU12 Apr 202600:30:50

In this episode of *PICU Doc on Call*, Drs. Monica Gray, Pradip Kamat, and Rahul Damania chat about a 17-year-old girl who ended up with acute liver failure after she intentionally took 22.5 grams of acetaminophen. She came in 48 hours later with really high transaminases and an INR of 5.5, so she was admitted to the PICU. The hosts break down how acetaminophen affects the body, walk through its four clinical stages, and discuss how to manage it—focusing on N-acetylcysteine as the primary antidote. They also touch on other treatments, like fomepizole. Thankfully, this patient recovered without needing a liver transplant, which really shows how important it is to have a team approach with intensivists, hepatologists, toxicologists, and psychiatry all working together.

Show Highlights:

  • Clinical case presentation of a 17-year-old girl with acetaminophen ingestion leading to acute liver failure
  • Mechanism of acetaminophen toxicity and its metabolic pathways
  • Epidemiology of acetaminophen toxicity in pediatric populations
  • Pathophysiology of acetaminophen overdose and its effects on liver function
  • Clinical manifestations and progression of acetaminophen toxicity through various stages
  • Evaluation and diagnostic criteria for assessing acetaminophen toxicity
  • Management strategies for acetaminophen overdose, including the use of N-acetylcysteine (NAC).
  • Discussion of adjunctive therapies such as fomepizole in severe cases.
  • Importance of supportive care in managing complications of acute liver failure
  • An interdisciplinary approach to treatment involving various medical specialties

References:

Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter ***.

Reference 1: 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report. Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, Rivers LJ, Pham NPT, Ryan ML. Clin Toxicol (Phila). 2020;58(12):1360.

Reference 2: Pepin L, Matsler N, Fontes A, Heard K, Flaherty BF, Monte AA. Fomepizole Therapy for Acetaminophen-Induced Liver Failure in an Infant. Pediatrics. 2023 Oct 1;152(4):e2022061033. doi:10.1542/peds. 2022-061033. PMID: 37681263.

Reference 3. Chiew AL, Buckley NA. Acetaminophen Poisoning. Crit Care Clin. 2021 Jul;37(3):543-561.

Reference 4. Squires JE, Alonso EM, Ibrahim SH, Kasper V, Kehar M, Martinez M, Squires RH. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure. J Pediatr Gastroenterol Nutr. 2022 Jan 1;74(1):138-158. doi: 10.1097/MPG.0000000000003268. PMID: 34347674.

Don’t Poke It, Spray It: The Intranasal Medication Playbook29 Mar 202600:20:49

In this episode of "PICU Doc on Call," Drs. Monica Gray, Pradip Kamat, and Rahul Damania discuss the use of intranasal medications in pediatric intensive care. Using the case of a four-month-old infant needing an MRI, they explore when and why intranasal drugs are preferred over IV access, the science behind nasal drug delivery, safe administration techniques, and common medications used. The episode highlights the benefits of intranasal sedation—such as rapid onset and needle-free delivery—while emphasizing teamwork and careful monitoring for safe, effective pediatric care.

Show Highlights:

  • Use of intranasal medications in pediatric intensive care settings
  • Case study of a four-month-old infant requiring sedation for an MRI.
  • Advantages of intranasal delivery over IV access
  • Pharmacokinetics and neuroanatomy related to intranasal drug absorption
  • Techniques for safe and effective administration of intranasal medications
  • Comparison of intranasal dosing to oral and IV routes
  • Common intranasal medications used in the pediatric ICU
  • Importance of timing and monitoring during sedation procedures
  • Teamwork and communication in administering intranasal medications
  • Clinical applications and implications for patient comfort and care delivery

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter ***.
  • Reference 1: Tsze DS, Woodward HA, McLaren SH, Leu CS, Venn AMR, Hu NY, Flores-Sanchez PL, Stefan BR, Shen ST, Ekladios MJ, Cravero JP, Dayan PS. Optimal Dose of Intranasal Midazolam for Procedural Sedation in Children: A Randomized Clinical Trial. JAMA Pediatr. 2025 Sep 1;179(9):979-986. doi: 10.1001/jamapediatrics. 2025.2181.
  • Reference 2: Prescott MG, Iakovleva E, Simpson MR, Pedersen SA, Munblit D, Vallersnes OM, Austad B. Intranasal analgesia for acute moderate to severe pain in children - a systematic review and meta-analysis. BMC Pediatr. 2023 Aug 18;23(1):405. doi: 10.1186/s12887-023-04203-x.
  • Reference 3: Chabowski L, Mahboobi Z, Navolokina A. Intranasal ketamine for procedural sedation in children. Am J Emerg Med. 2023 Jun;68:195. doi: 10.1016/j.ajem.2023.04.013.
  • Reference 4: Sulton C, Kamat P, Mallory M, Reynolds J. The Use of Intranasal Dexmedetomidine and Midazolam for Sedated Magnetic Resonance Imaging in Children: A Report From the Pediatric Sedation Research Consortium. Pediatr Emerg Care. 2020 Mar;36(3):138-142. doi: 10.1097/PEC.0000000000001199.

Mean Arterial Pressure in the PICU15 Mar 202600:11:12

In this special “PICU Doc On Call Shorts” episode, pediatric ICU physicians Dr. Monica Gray, Dr. Pradip Kamat, and Dr. Rahul Damania break down the concept of Mean Arterial Pressure (MAP). Using a case of a six-year-old in septic shock, they discuss how to calculate MAP, normal pediatric values, and the physiological determinants and clinical significance of MAP. The hosts highlight MAP’s role in guiding management of critically ill children, review autonomic and endothelial regulation, and reinforce learning with a board-style question. This episode emphasizes practical bedside application for pediatric interns and ICU providers.

Show Highlights:

  1. Overview of Mean Arterial Pressure (MAP) and its clinical significance in pediatric critical care.
  2. Introduction of a clinical case involving a 6-year-old child in septic shock.
  3. Explanation of the formula for calculating MAP and its application to the clinical case.
  4. Discussion of normal reference values for MAP in children and their clinical implications.
  5. Physiological determinants of MAP, including cardiac output and systemic vascular resistance.
  6. Role of the autonomic nervous system in regulating MAP through baroreceptor reflexes.
  7. Importance of maintaining adequate MAP for organ perfusion, particularly in critically ill patients.
  8. Clinical applications of MAP monitoring and management strategies in the PICU.
  9. Summary of key takeaways regarding MAP calculation, physiological determinants, and clinical relevance.
  10. Mention of related topics, such as invasive versus non-invasive blood pressure monitoring.

References:

  1. DeMers D, Wachs D. Physiology, Mean Arterial Pressure. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
  2. Pediatric Blood Pressure Metrics and Hypotension Thresholds (details the task force data used to derive the 5th and 50th percentile MAP estimation formulas for children)
  3. Berlin DA, Bakker J. Starling curves and central venous pressure. Crit Care. 2015 Feb 16;19(1):55.
  4. Magder S. Volume and its relationship to cardiac output and venous return. Crit Care. 2016 Sep 10;20(1):271

Von Willebrand Disease in the PICU08 Feb 202600:24:53

In this episode of "PICU Doc on Call," Drs. Pradip Kamat and Rahul Damania dive into a pediatric ICU case involving a 4-year-old girl who presents with severe anemia and bleeding, ultimately diagnosed with von Willebrand disease (VWD). They chat about the causes and different types of VWD, walk through the key clinical features, and break down how to diagnose and manage this condition. Drs. Kamat and Damania highlight the important roles of desmopressin and factor concentrates in treatment. Throughout the episode, they stress the need to recognize VWD in kids who have mucosal bleeding and offer practical tips for intensivists on lab evaluation and treatment strategies for this common inherited bleeding disorder.

Show Nighlights:

  1. Clinical case discussion of a 4-year-old girl with severe anemia and bleeding symptoms
  2. Diagnosis of von Willebrand disease (VWD) and its significance in pediatric critical care
  3. Etiology and pathogenesis of von Willebrand disease
  4. Classification of von Willebrand disease into types (Type 1, Type 2 with subtypes, Type 3)
  5. Clinical manifestations and symptoms associated with VWD
  6. Diagnostic approach for identifying von Willebrand disease, including laboratory tests
  7. Management strategies for VWD, including desmopressin and von Willebrand factor concentrates
  8. Role of adjunctive therapies such as antifibrinolytics and hormonal treatments
  9. Importance of multidisciplinary collaboration in managing complex bleeding disorders
  10. Overview of the pathophysiology of von Willebrand factor and its role in hemostasis

References:

  1. Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter ***.
  2. Reference 1: Leebeek FW, Eikenboom JC. Von Willebrand's Disease. N Engl J Med. 2016 Nov 24;375(21):2067-2080.
  3. Reference 2: Ng C, Motto DG, Di Paola J. Diagnostic approach to von Willebrand disease. Blood. 2015 Mar 26;125(13):2029-37.
  4. Platton S, Baker P, Bowyer A, et al. Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors' Organisation and the British Society for Hematology. Br J Haematol 2024 May;204(5):1714-1731.
  5. Mohinani A, Patel S, Tan V, Kartika T, Olson S, DeLoughery TG, Shatzel J. Desmopressin as a hemostatic and blood-sparing agent in bleeding disorders. Eur J Haematol. 2023 May;110(5):470-479. doi: 10.1111/ejh.13930. Epub 2023 Feb 12. PMID: 36656570; PMCID: PMC10073345.

Management of Rectal Bleeding in the PICU25 Jan 202600:18:26

In this episode of "PICU Doc On Call," Drs. Pradip Kamat and Rahul Damania discuss the acute management of a 14-year-old boy with severe rectal bleeding and hypertension, ultimately diagnosed with inflammatory bowel disease (IBD). They review the approach to pediatric lower GI bleeding, diagnostic workup, and imaging, emphasizing early recognition and resuscitation. They outline IBD management, including steroids, biologics such as infliximab, and nutritional support, while highlighting the importance of screening for infections before immunosuppression. The episode provides practical insights for PICU physicians on handling acute GI emergencies in children.

Show Nighlights:

  1. Clinical case of a 14-year-old male with hypertension and rectal bleeding.
  2. Diagnosis of inflammatory bowel disease (IBD) following significant blood loss.
  3. Approach to pediatric rectal bleeding and its implications.
  4. Diagnostic workup including laboratory tests and imaging modalities.
  5. Management strategies for IBD in acute pediatric care.
  6. Importance of early recognition and resuscitation in cases of shock.
  7. Physiological principles related to blood loss and shock in children.
  8. Differential diagnoses for lower gastrointestinal bleeding in pediatrics.
  9. Initial evaluation and stabilization protocols for pediatric patients.
  10. Nutritional support and multidisciplinary care in managing IBD.

References:

  1. Romano C, Oliva S, Martellossi S, et al. Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology. World J Gastroenterol. 2017;23(8):1326-1337.
  2. Pai AK, Fox VL. Gastrointestinal bleeding and management. Pediatr Clin North Am. 2017;64(3):543-561.
  3. Padilla BE, Moses W. Lower gastrointestinal bleeding and intussusception. Surg Clin North Am. 2017;97(1):63-80.
  4. Kaur M, Dalal RL, Shaffer S, Schwartz DA, Rubin DT. Inpatient management of inflammatory bowel disease-related complications. Clin Gastroenterol Hepatol. 2020;18(11):2417-2428.
  5. Ashton JJ, Ennis S, Beattie RM. Early-onset paediatric inflammatory bowel disease. Lancet Child Adolesc Health. 2017;1(2):147-158.
  6. Bouhuys M, Lexmond WS, van Rheenen PF. Pediatric inflammatory bowel disease. Pediatrics. 2022;150(6):e2022059341.
  7. Rosen MJ, Dhawan A, Saeed SA. Inflammatory bowel disease in children and adolescents. JAMA Pediatr. 2015;169(11):1053-1060.
  8. Conrad MA, Rosh JR. Pediatric Inflammatory Bowel Disease. Pediatr Clin North Am. 2017 Jun;64(3):577-591.
  9. Turner D, Ruemmele FM, Orlanski-Meyer E, et al. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):257-291, correction can be found in J Pediatr Gastroenterol Nutr 2020 Dec;71(6):794.

Approach to Hypoglycemia in the PICU28 Dec 202500:27:46

In this episode of "PICU Doc on Call," Dr. Pradip Kamat and Dr. Rahul Damania dive into a fascinating case of a 9-month-old infant who comes in with hypoglycemia and seizures. Together, they break down the basics of glucose metabolism, walk through the causes of hypoglycemia, and discuss the best diagnostic strategies and acute management steps. They put a special spotlight on using diazoxide for hyperinsulinemic hypoglycemia, discussing not only how it works but also its potential side effects. The conversation also discusses dietary interventions for metabolic disorders and highlights the importance of rapid diagnosis and personalized treatment.

Show Highlights:

  1. Pediatric hypoglycemia and its implications in infants
  2. Case study of a 9-month-old infant with hypoglycemia and seizures
  3. Physiology of glucose metabolism and its regulation
  4. Causes of hypoglycemia, categorized into primary and secondary etiologies
  5. Diagnostic approaches for identifying the cause of hypoglycemia
  6. Initial management strategies for acute hypoglycemia
  7. Long-term treatment options based on underlying causes
  8. Importance of timely diagnosis and intervention in the PICU setting
  9. Pharmacologic management of hyperinsulinemic hypoglycemia, including the use of diazoxide
  10. Multidisciplinary care and follow-up for pediatric patients with hypoglycemia

References:
  1. Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter 84 Alder M et al. Pediatric Sepsis. Pages 1293-1309
  2. Honarmand K, Sirimaturos M, Hirshberg EL, Bircher NG, Agus MSD, Carpenter DL, Downs CR, Farrington EA, Freire AX, Grow A, Irving SY, Krinsley JS, Lanspa MJ, Long MT, Nagpal D, Preiser JC, Srinivasan V, Umpierrez GE, Jacobi J. Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Children and Adults 2024. Crit Care Med. 2024 Apr 1;52(4):e161-e181. doi: 10.1097/CCM.0000000000006174. Epub 2024 Jan 19. PMID: 38240484.
  3. Rosenfeld E, Thornton PS. Hypoglycemia in Neonates, Infants, and Children. 2023 Aug 22. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 37665756.
  4. Rayas MS, Salehi M. Non-Diabetic Hypoglycemia. 2024 Jan 27. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 27099902.
  5. Nakrani MN, Wineland RH, Anjum F. Physiology, Glucose Metabolism. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560599/
  6. Chen X, Feng L, Yao H, Yang L, Qin Y. Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis. PLoS One. 2021 Feb 11;16(2):e0246463. doi: 10.1371/journal.pone.0246463. PMID: 33571197; PMCID: PMC7877589.
  7. Kucharczyk P, Albano G, Deisl C, Ho TM, Bargagli M, Anderegg M, Wuest S, Konrad D, Fuster DG. Thiazides Attenuate Insulin Secretion Through Inhibition of Mitochondrial Carbonic Anhydrase 5b in β -Islet Cells in Mice. J Am Soc Nephrol. 2023 Jul 1;34(7):1179-1190. Doi: 10.1681/ASN.0000000000000122. Epub 2023 Apr 17. PMID: 36927842; PMCID: PMC10356162.

Desaturation in the Intubated Patient in the PICU23 Nov 202500:30:36

Today, Dr. Monica Gray, Dr. Pradip Kamat, and Rahul Damania discuss a critical case involving a 10-year-old boy who developed post-intubation desaturation. Using the DOPE mnemonic (Displacement, Obstruction, Pneumothorax, Equipment failure), they systematically troubleshoot the emergency, highlighting the importance of teamwork, capnography, and manual ventilation. The team emphasizes structured approaches, simulation training, and essential bedside tools to ensure rapid, effective management of acute deterioration in intubated children, turning a life-threatening crisis into a controlled, solvable situation.

Show Highlights:

  • Clinical case discussion of a ten-year-old boy with post-intubation desaturation in the pediatric ICU
  • Use of the "DOPE" mnemonic (Displacement, Obstruction, Pneumothorax, Equipment failure) for troubleshooting
  • Systematic approaches in emergency situations in pediatric critical care
  • Assessment and management of sudden desaturation in intubated patients
  • Evaluation of potential causes of desaturation, including tube displacement and obstruction
  • Role of equipment failure in acute deterioration and strategies to address it
  • Significance of continuous capnography and manual ventilation techniques
  • Prevention strategies for unplanned extubation in pediatric ICU settings
  • Emphasis on teamwork, communication, and simulation training in crisis management
  • Review of literature insights related to hypoxemia and equipment issues in pediatric intubation

References:

  • Topjian AA, et al. Part 4: Pediatric Basic and Advanced Life Support—2020 AHA PALS Guidelines. Circulation. 2020.Foundational pediatric resuscitation guidance endorsing early switch to manual ventilation and structured troubleshooting for the deteriorating intubated child.
  • Cook TM, et al. Major complications of airway management in the UK: NAP4. British Journal of Anaesthesia. 2011.Seminal audit highlighting ICU/ED airway failures and the critical role of waveform capnography in preventing unrecognized esophageal intubation.
  • Volpicelli G, et al. International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Medicine. 2012. High-impact consensus placing lung ultrasound at the bedside to rapidly diagnose pneumothorax during post-intubation deterioration.
  • Prekker ME, et al. Video vs direct laryngoscopy for ED intubation—randomized trial. New England Journal of Medicine. 2023.NEJM RCT showing higher first-pass success with video laryngoscopy—relevant to preventing displacement/misplacement drivers of desaturation.
  • Chrimes N, et al. Preventing unrecognised oesophageal intubation: consensus guideline. Anaesthesia. 2022.Modern, practice-changing guidance: sustained waveform capnography is the mainstay to exclude esophageal placement and avert catastrophic hypoxemia.




Paroxysmal Nocturnal Hemoglobinuria in the PICU09 Nov 202500:21:59

Welcome to "PICU Doc on Call," the podcast where the world of pediatric critical care comes alive! Today, Dr. Monica Gray, Dr. Pradip Kamat, and Rahul Damania delve into a fascinating case involving a 16-year-old male presenting with headache, photophobia, anemia, and cerebral venous thrombosis. After some detective work, the diagnosis? Paroxysmal nocturnal hemoglobinuria, or PNH.

Join us as we break down the pathogenesis and clinical features of PNH, walk through the diagnostic workup, and discuss management strategies, especially the game-changing role of complement inhibitors like Eculizumab. We’ll also review this patient’s clinical journey, highlighting the key pearls for recognizing and treating PNH in the pediatric intensive care unit.

So, tune in to hear more!

Show Highlights:

  • Clinical case presentation of a 16-year-old male with symptoms including headache, photophobia, and anemia
  • Diagnosis of paroxysmal nocturnal hemoglobinuria (PNH) and its clinical significance
  • Pathogenesis of PNH, including the role of the PIGA gene mutation and GPI-anchored proteins
  • Clinical features and complications associated with PNH, such as thrombosis and hemolysis
  • Diagnostic workup for PNH, including laboratory tests and flow cytometry
  • Management strategies for PNH, focusing on complement inhibitors like Eculizumab
  • Importance of supportive care in the PICU for patients with PNH
  • Discussion of emerging therapies and advancements in PNH treatment
  • Patient outcome and clinical course following treatment for PNH
  • Key takeaways regarding the diagnosis and management of PNH in pediatric intensive care

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care.
  • Reference 1: Brodsky RA. Paroxysmal nocturnal hemoglobinuria. Blood. 2014 Oct 30;124(18):2804-11.
  • Reference 2 Waheed A, Shammo J, Dingli D. Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape. Blood Rev. 2024 Mar;64:101158.
  • Reference 3: Kokoris S, Polyviou A, Evangelidis P, Grouzi E, Valsami S, Tragiannidis K, Gialeraki A, Tsakiris DA, Gavriilaki E. Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment. Int. J. Mol. Sci. 2024 Nov 11;25(22):12104.

Brains & Drains: The EVD survival guide for the PICU26 Oct 202500:31:05

In today’s episode, Dr. Monica Gray and Dr. Pradip Kamat sit down with neurosurgeon Dr. Neal Laxpati, MD, PhD, to chat about intracranial pressure (ICP) monitoring in pediatric critical care. Using real case studies, they dive into how and when to use external ventricular drains (EVDs) and ICP bolts, walking listeners through setup, potential risks, and everyday challenges. The group discusses device complications, ways to prevent infections, how to interpret waveforms, and shares practical bedside tips. It’s a must-listen for intensivists looking for hands-on advice and key insights to help optimize care for kids with brain injuries or hydrocephalus.

Show Highlights:

  • Pediatric critical care unit (PCU) case discussions
  • Intracranial pressure (ICP) monitoring in pediatric patients
  • Case studies involving a 10-year-old girl with diffuse midline glioma and a 16-year-old male with a ruptured arteriovenous malformation (AVM)
  • Cerebrospinal fluid (CSF) physiology and its role in ICP management
  • Types of ICP monitoring devices: external ventricular drains (EVDs) and intraparenchymal monitors
  • Indications and complications associated with ICP monitoring
  • Interpretation of ICP waveforms and their clinical significance
  • Management strategies for elevated ICP and CSF drainage
  • Risks and challenges of ICP monitoring, including infection and device malfunction
  • Importance of interdisciplinary communication and meticulous bedside care in pediatric critical care settings

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter 118. Traumatic brain injury. Kochaneck et al. Page 1375 -1400
  • Rogers textbook:
  • Reference 1: Forsyth RJ, Parslow RC, Tasker RC, Hawley CA, Morris KP; UK Paediatric Traumatic Brain Injury Study Group; Paediatric Intensive Care Society Study Group (PICSSG). Prediction of raised intracranial pressure complicating severe traumatic brain injury in children: implications for trial design. Pediatr Crit Care Med. 2008 Jan;9(1):8-14. doi: 10.1097/01.PCC.0000298759.78616.3A. PMID: 18477907.
  • Reference 2: Appavu B, Burrows BT, Foldes S, Adelson PD. Approaches to Multimodality Monitoring in Pediatric Traumatic Brain Injury. Front Neurol. 2019 Nov 26;10:1261. doi: 10.3389/fneur.2019.01261. PMID: 32038449; PMCID: PMC6988791.

May the Flow Be with You: Practical Hemodynamics in the PICU12 Oct 202500:32:27

Ever wondered how PICU teams make those critical calls about blood pressure and vasoactive meds? On this episode, Dr. Monica Gray and Dr. Pradip Kamat dive into the real-world questions that come up during pediatric intensive care rounds. They break down the pros and cons of arterial line versus non-invasive cuff measurements, talk through blood pressure targets for tough cases like sepsis and brain injury, and share practical tips for weaning kids off vasoactive drugs. With a focus on the latest guidelines and research, Monica and Pradip offer actionable advice to help you fine-tune hemodynamic management for your sickest patients. Tune in!

Show Highlights:

  • Relationship between blood pressure and cardiac output in pediatric patients
  • Comparison of arterial line (invasive) versus non-invasive cuff measurements for blood pressure monitoring in the PICU
  • Blood pressure targets for critical illnesses such as sepsis, traumatic brain injury, and respiratory failure in children
  • Strategies for weaning vasoactive medications in critically ill pediatric patients
  • Importance of accurate blood pressure measurement and monitoring in the PICU
  • Discussion of organ autoregulation and its impact on blood pressure management
  • Clinical assessment and individualized care in setting blood pressure goals
  • Recommendations for initial vasoactive agents in pediatric septic shock
  • Challenges and considerations in vasoactive medication selection and weaning
  • Need for further research on pediatric vasoactive medication management strategies

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter 110. Alder M et al. Pediatric Sepsis. Pages 1293-1309.
  • Rogers Textbook of Pediatric Critical Care Medicine. Chapter 88. Fitzgerald J et al. Bacterial Sepsis.Pages 1469-1485.
  • Reference 1 Weiss S. Vasoactive Selection for Pediatric Septic Shock-Where to begin. JAMA Network Open, 2025;8(4):e254726.
  • Reference 2 Schlapbach LJ, Watson RS, Sorce LR, Argent AC, Menon K, Hall MW, Akech S, Albers DJ, Alpern ER, Balamuth F, Bembea M, Biban P, Carrol ED, Chiotos K, Chisti MJ, DeWitt PE, Evans I, Flauzino de Oliveira C, Horvat CM, Inwald D, Ishimine P, Jaramillo-Bustamante JC, Levin M, Lodha R, Martin B, Nadel S, Nakagawa S, Peters MJ, Randolph AG, Ranjit S, Rebull MN, Russell S, Scott HF, de Souza DC, Tissieres P, Weiss SL, Wiens MO, Wynn JL, Kissoon N, Zimmerman JJ, Sanchez-Pinto LN, Bennett TD; Society of Critical Care Medicine Pediatric Sepsis Definition Task Force. International Consensus Criteria for Pediatric Sepsis and Septic Shock. JAMA. 2024 Feb 27;331(8):665-674.

Burgers, Fries, and Weak Thighs - A Case of Familial Hypokalemic Periodic Paralysis28 Sep 202500:21:17

Welcome to PICU Doc on Call, the podcast where we break down real-life cases from the pediatric intensive care unit and share practical insights for clinicians everywhere! I’m Dr. Monica Gray, and I’m joined by my co-host, Dr. Pradip Kamat.

Today, we’re diving into a fascinating case: a 13-year-old boy who suddenly developed muscle weakness and was found to have severe hypokalemia. After some detective work, he was diagnosed with familial hypokalemic periodic paralysis, a rare but important condition to recognize in the PICU.

We’ll discuss the genetic underpinnings, classic clinical features, and common triggers associated with this disorder. Additionally, we’ll guide you through the differential diagnosis, key management strategies, such as potassium supplementation, and explain why genetic testing is so crucial. We’ll also cover essential considerations for anesthesia and cardiac monitoring in these patients.

Whether you’re a pediatric intensivist or just interested in acute neuromuscular care, stick around for some practical pearls you can use on your next shift!

Show Highlights:

  • Clinical case discussion of a 13-year-old male patient with muscle weakness and hypokalemia
  • Diagnosis and management of familial hypokalemic periodic paralysis
  • Genetic basis and mutations associated with hypokalemic periodic paralysis (CACNA1S and SCN4A)
  • Physiological mechanisms underlying hypokalemic periodic paralysis
  • Common clinical presentations and triggers for episodes of muscle weakness
  • Differential diagnoses for muscle weakness and hypokalemia in pediatric patients
  • Laboratory investigations to confirm hypokalemic periodic paralysis
  • Treatment options for hypokalemic periodic paralysis, including potassium supplementation and prophylactic medications
  • Importance of avoiding triggers and coordinating care with anesthesia

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter 68: Weimer M et al. Acute neuromuscular disease and disorders page 840
  • Rogers Textbook of Pediatric Intensive Care Medicine: Management of Sodium and Potassium Disorders. Pages 1876- 1883
  • Reference 1: Weber F, Lehmann-Horn F. Hypokalemic Periodic Paralysis. 2002 Apr 30 [Updated 2018 Jul 26]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1338/
  • Reference 2: Channelopathies. Clin Exp Pediatr. 2014;57(1):1-18.   Published online January 31, 2014**DOI: https://doi.org/10.3345/kjp.2014.57.1.1**
  • Reference 3: Statland JM, Fontaine B, Hanna MG, Johnson NE, Kissel JT, Sansone VA, Shieh PB, Tawil RN, Trivedi J, Cannon SC, Griggs RC. Review of the Diagnosis and Treatment of Periodic Paralysis. Muscle Nerve. 2018 Apr;57(4):522-530.

Choose your Potion: Intubation Medication07 Sep 202500:35:25

Learn how to sharpen your pediatric intubation skills and make evidence-based decisions at the bedside. Today, Dr. Pradip Kamat, Dr. Monica Gray, and Dr. Rahul Damania expertly dissect the nuances of selecting optimal induction agents for critically ill children in the PICU. Through engaging, real-world case scenarios, our hosts guide you through drug choices in complex situations such as cardiogenic shock, septic shock, and elevated intracranial pressure—always prioritizing hemodynamic stability and patient safety. Gain valuable insights into the advantages, limitations, and clinical pearls of agents like propofol, fentanyl, ketamine, and midazolam, along with practical strategies for rapid sequence intubation, neuromuscular blockade, and individualized patient care. Don’t miss this high-yield discussion, packed with actionable knowledge!

Show Highlights:

  • Induction agents for endotracheal intubation in critically ill children
  • Clinical scenarios highlighting optimal choices of induction agents and neuromuscular blockers
  • Importance of maintaining hemodynamic stability during intubation
  • Pharmacology and clinical considerations of various induction agents (e.g., propofol, ketamine, fentanyl, etomidate)
  • Use of neuromuscular blocking agents (NMBAs) in pediatric intubation
  • Differences between depolarizing and non-depolarizing neuromuscular blockers
  • Risks associated with specific induction agents in patients with cardiac dysfunction or septic shock
  • Modified rapid sequence intubation (RSI) techniques for unstable patients
  • Key takeaways for managing critically ill pediatric patients requiring intubation
  • Practical tips for optimizing intubation conditions and minimizing complications

References:

  1. Fuhrman & Zimmerman - Textbook of Pediatric Critical Care 6th Edition. Chapters 127 - 135, Pages 1510 - 1610
  2. Hendrix JM, Regunath H. Intubation Endotracheal Tube Medications. [Updated 2025 Jan 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459276/
  3. Agrawal, Dewesh. Rapid sequence intubation (RSI) in children for emergency medicine: Medications for sedation and paralysis. UpToDate. Last updated Dec 4, 2024.
  4. Vanlinthout LE, Geniets B, Driessen JJ, Saldien V, Lapré R, Berghmans J, Uwimpuhwe G, Hens N. Neuromuscular-blocking agents for tracheal intubation in pediatric patients (0-12 years): A systematic review and meta-analysis. Paediatr Anaesth. 2020 Apr;30(4):401-414. doi: 10.1111/pan.13806. Epub 2020 Mar 9. PMID: 31887248.
  5. Tarquinio KM, Howell JD, Montgomery V, Turner DA, Hsing DD, Parker MM, Brown CA 3rd, Walls RM, Nadkarni VM, Nishisaki A; National Emergency Airway Registry for Children; Pediatric Acute Lung Injury and Sepsis Investigators Network. Current medication practice and tracheal intubation safety outcomes from a prospective multicenter observational cohort study. Pediatr Crit Care Med. 2015 Mar;16(3):210-8. doi: 10.1097/PCC.0000000000000319. PMID: 25581629.
  6. Conway JA, Kharayat P, Sanders RC Jr, Nett S, Weiss SL, Edwards LR, Breuer R, Kirby A, Krawiec C, Page-Goertz C, Polikoff L, Turner DA, Shults J, Giuliano JS Jr, Orioles A, Balkandier S, Emeriaud G, Rehder KJ, Kian Boon JL, Shenoi A, Vanderford P, Nuthall G, Lee A, Zeqo J, Parsons SJ, Furlong-Dillard J, Meyer K, Harwayne-Gidansky I, Jung P, Adu-Darko M, Bysani GK, McCarthy MA, Shlomovich M, Toedt-Pingel I, Branca A, Esperanza MC, Al-Subu AM, Pinto M, Tallent S, Shetty R, Thyagarajan S, Ikeyama T, Tarquinio KM, Skippen P, Kasagi M, Howell JD, Nadkarni VM, Nishisaki A; National Emergency Airway Registry for Children (NEAR4KIDS) and for the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI). Ketamine Use for Tracheal Intubation in Critically Ill Children Is Associated With a Lower Occurrence of Adverse Hemodynamic Events. Crit Care Med. 2020 Jun;48(6):e489-e497. doi: 10.1097/CCM.0000000000004314. PMID: 32317603.
  7. Zanza C, Piccolella F, Racca F, Romenskaya T, Longhitano Y, Franceschi F, Savioli G, Bertozzi G, De Simone S, Cipolloni L, La Russa R. Ketamine in Acute Brain Injury: Current Opinion Following Cerebral Circulation and Electrical Activity. Healthcare (Basel). 2022 Mar 17;10(3):566. doi: 10.3390/healthcare10030566. PMID: 35327044; PMCID: PMC8949520.
  8. Zeiler FA, Teitelbaum J, West M, Gillman LM. The ketamine effect on ICP in traumatic brain injury. Neurocrit Care. 2014 Aug;21(1):163-73. doi: 10.1007/s12028-013-9950-y. PMID: 24515638.

Splenic Sequestration (Sickle Cell) in the PICU24 Aug 202500:28:51

Ready for a deep dive into a real-life pediatric ICU situation? Today,  Dr. Pradip Kamat, Dr. Monica Gray, and Dr. Rahul Damania will walk you through the case of a seven-year-old girl with Hemoglobin SC (HbSC) disease, who presents with abdominal swelling, pneumonia, low oxygen, and pain.

In this episode, our team unpacks the spleen’s anatomy and its crucial role in immunity, then zooms in on how sickle cell disease can throw a wrench in splenic function. You’ll hear how they approach the diagnosis and management of acute splenic sequestration crisis, sharing clinical pearls along the way. Plus, they’ll break down why quick recognition is so important and discuss strategies for both immediate and long-term care in pediatric sickle cell patients. Don’t miss these practical insights from the frontlines of pediatric critical care!

Show Highlights:

  • Case study of a seven-year-old girl with hemoglobin SC disease
  • Presentation of symptoms: abdominal distension, pneumonia, hypoxia, and body pain
  • Discussion of acute splenic sequestration crisis as a complication of sickle cell disease
  • Anatomy and physiology of the spleen
  • The role of the spleen in sickle cell disease and how sickled cells affect splenic function
  • Acute splenic sequestration crisis, including clinical features and laboratory evaluations
  • Management strategies for acute splenic sequestration crisis in the ICU
  • Importance of blood transfusions and supportive care in treatment
  • Prophylactic measures to prevent recurrence of splenic sequestration
  • Educational emphasis on recognizing clinical signs and the need for timely intervention

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter 88. Hemoglobinopathies. Baender, MA, Marsh Anne. Pages: 1457-1470
  • Rogers' textbook of pediatric intensive care: Hematologic Emergencies. McCory MC, Bhar S, and Blaine E. Pages 2003-2005
  • Brousse V, Buffet P, Rees D. The spleen and sickle cell disease: the sick(led) spleen. Br J Haematol. 2014 Jul;166(2):165-76. doi: 10.1111/bjh 12950. Epub 2014 May 26. PMID: 24862308.
  • Waleed S, Aldabsa M, Gouher S. Splenic Sequestration Induced by Parvovirus B19: A Case Report. Cureus. 2024 May 23;16(5):e60937. doi: 10.7759/cureus. 60937. PMID: 38915956; PMCID: PMC11195323.
  • Solanki DL, Kletter GG, Castro O. Acute splenic sequestration crises in adults with sickle cell disease. Am J Med. 1986 May;80(5):985-90. doi: 10.1016/0002-9343(86)90649-2. PMID: 3706382.
  • Karna B, Jha SK, Al Zaabi E. Hemoglobin C Disease. [Updated 2023 May 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559043/

Emerging Neurologic Autoimmune Disorders (MOGAD) in the PICU10 Aug 202500:27:42

Welcome to "PICU Doc on Call," the podcast where real cases meet real expertise at the bedside! Join Dr. Monica Gray, Dr. Pradip Kamat, and Dr. Rahul Damania as they unravel the mysteries of pediatric critical care. In today’s episode, our team dives into the compelling case of a previously healthy seven-year-old girl who arrives with seizures, right arm weakness, and sudden respiratory failure. Together, they’ll break down the diagnosis and management of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, also known as MOGAD. This autoimmune demyelinating disorder can challenge even the most seasoned clinicians. 

Tune in as our experts walk you through the clinical features, essential diagnostic workup, and the critical importance of early immunosuppressive therapy. Whether you’re at the bedside or on the go, this episode is packed with practical pearls and a multidisciplinary approach to recognizing and treating acute pediatric neuroimmunological emergencies in the PICU. Let’s get started!

Show Highlights:

  • Presentation of a complex pediatric case involving a seven-year-old girl with new-onset seizures and acute respiratory failure
  • Discussion of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) as an autoimmune demyelinating disorder
  • Overview of the clinical presentation and diagnostic criteria for autoimmune encephalitis
  • Importance of a broad differential diagnosis, including infectious and autoimmune causes, in pediatric patients with seizures and neurological deficits
  • Diagnostic approach involving MRI, lumbar puncture, and antibody testing for MOGAD
  • Management strategies for MOGAD, including stabilization, seizure control, and immunosuppressive therapy
  • Neurocritical care considerations for monitoring and treating elevated intracranial pressure
  • Long-term management challenges and the need for multidisciplinary care in pediatric patients with MOGAD
  • Discussion of potential outcomes and the risk of relapse in children with MOGAD.
  • Emphasis on the importance of early and comprehensive diagnostic testing to avoid misdiagnosis

References:

  1. Fuhrman & Zimmerman - Pediatric Critical Care 6th Edition, Chapter 64
  2. Gole S, Anand A. Autoimmune Encephalitis. [Updated 2023 Jan 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK578203/
  3. Salama S, Khan M, Pardo S, Izbudak I, Levy M. MOG antibody-associated encephalomyelitis/encephalitis. Mult Scler. 2019 Oct;25(11):1427-1433. doi: 10.1177/1352458519837705. Epub 2019 Mar 25. PMID: 30907249; PMCID: PMC6751007
  4. Lancaster E. The Diagnosis and Treatment of Autoimmune Encephalitis. J Clin Neurol. 2016 Jan;12(1):1-13. doi: 10.3988/jcn.2016.12.1.1. PMID: 26754777; PMCID: PMC4712273.
  5. Fisher KS, Illner A, Kannan V. Pediatric neuroinflammatory diseases in the intensive care unit. Semin Pediatr Neurol. 2024 Apr;49:101118. Doi: 10.1016/j.spen.2024.101118. Epub 2024 Feb 1. PMID: 38677797.
  6. Hébert J, Muccilli A, Wennberg RA, Tang-Wai DF. Autoimmune Encephalitis and Autoantibodies: A Review of Clinical Implications. J Appl Lab Med. 2022 Jan 5;7(1):81-98. Doi: 10.1093/jalm/jfab102. PMID: 34996085.
  7. Lopez JA, Denkova M, Ramanathan S, Dale RC, Brilot F. Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease. Clin Transl Immunology. 2021 Jul 26;10(7):e1316. doi: 10.1002/cti2.1316. PMID: 34336206; PMCID: PMC8312887.

Cardiopulmonary Interactions in the PICU27 Jul 202500:20:24

Have you ever wondered what happens when a toddler gets into something they definitely shouldn’t? Today, Dr. Monica Gray, Dr. Pradip Kamat, and Dr. Rahul Damania discuss the case of an 18-month-old boy who accidentally ingested concentrated bleach, presenting with stridor, drooling, and vomiting. They review the clinical approach to caustic ingestions in children, including airway management, diagnostic workup, and the roles of endoscopy, steroids, and multidisciplinary care. The episode also highlights potential complications such as esophageal strictures and cancer, emphasizes prevention strategies, and provides key takeaways for intensivists managing similar pediatric emergencies. If you’re an intensivist or just want to know what to do in a pediatric emergency, don’t miss these essential takeaways for managing one of the scariest situations in the ER.

Show Highlights:

  • Case study of an 18-month-old boy who ingested concentrated bleach
  • Clinical presentation including symptoms like stridor, drooling, and vomiting
  • Management strategies for caustic ingestions in children
  • Importance of airway management and monitoring in cases of caustic ingestion
  • Diagnostic workup including imaging and endoscopy
  • Differential diagnosis considerations for similar presentations (e.g., button batteries, laundry detergent pods)
  • Mechanism of injury caused by alkaline substances like bleach
  • Long-term complications associated with caustic ingestions, such as esophageal strictures and cancer
  • Multidisciplinary approach to treatment involving various medical specialties
  • Prevention strategies to reduce the incidence of accidental caustic ingestions in children

References:

  • American Academy of Pediatrics – Pediatric Care Online: Esophageal Caustic Injury (AAP clinical guidance on caustic ingestions).
  • Fuhrman & Zimmerman’s Pediatric Critical Care textbook – Chapters on toxicology and gastrointestinal emergencies (covering caustic injury management and critical care approach).
  • Hoffman RS, et al. “Ingestion of Caustic Substances.” New England Journal of Medicine. 2020; 382(18):1739-1748. A comprehensive review of caustic ingestion injuries and management.
  • Arnold M, Numanoglu A. “Caustic ingestion in children – a review.” Semin Pediatr Surg. 2017;26(2):95-104. Review of epidemiology, pathophysiology, and treatment of caustic injuries in kids.
  • Johnson CM, Brigger MT. “The public health impact of pediatric caustic ingestion injuries.” Arch Otolaryngol Head Neck Surg. 2012;138(12):1111-1115. (Epidemiology study showing declining incidence).
  • Pediatric Critical Care Medicine (PCCM) Journal – various case reports and series on caustic ingestion (for case-based insights), and annual National Poison Data System reports (for statistics on pediatric poisonings).
  • Tringali A, et al. ESGE/ESPGHAN Pediatric GI Endoscopy Guidelines (Endoscopy, 2017) – Includes recommendations for endoscopy timing and steroid use in caustic ingestions.
  • Usta M, et al. “High doses of methylprednisolone in the management of caustic esophageal burns.” Pediatrics. 2014;133(6):E1518-24. (Key study demonstrating steroids benefit in grade 2b injuries).
  • Royal Children’s Hospital Melbourne – Clinical Practice Guidelines: Caustic Ingestions (2019) – Practical hospital guidelines emphasizing early intubation for airway threat, endoscopy within 24h, IV PPI, and supportive care.


Salty Saga of Hyponatremia and Hypotension in the PICU29 Jun 202500:39:31

Today, Dr. Monica Gray, Dr. Pradip Kamat, and Dr. Rahul Damania discuss two real-life pediatric cases of hyponatremia in the PICU. They talk through a case of a six-month-old baby with severe sodium depletion and a teenager dealing with cancer-related hyponatremia. The team breaks down the pathophysiology, walks us through the diagnostic workups, and discusses the careful management needed for these cases. They emphasize the importance of correcting sodium levels gradually and addressing the root cause of the problem. They share practical tips for intensivists and highlight why staying vigilant and following evidence-based care is so crucial when managing critically ill kids with electrolyte disturbances. Tune in to hear more!

Show Highlights:

  • Discussion of hyponatremia in pediatric patients, particularly in the PICU
  • Presentation of two case studies illustrating different presentations of hyponatremia
  • Examination of the pathophysiology of hyponatremia, including its classification into hypovolemic, euvolemic, and hypervolemic types
  • Overview of diagnostic investigations for hyponatremia, including volume status assessment and serum/urine electrolyte measurements
  • Management strategies for hyponatremia, emphasizing the importance of gradual correction of sodium levels
  • Risks associated with rapid correction of hyponatremia
  • Importance of fluid management in different types of hyponatremia
  • Role of pharmacological interventions in specific cases, such as SIADH
  • Clinical presentation and symptoms associated with hyponatremia in pediatric patients
  • Emphasis on continuous monitoring of sodium levels and clinical status during treatment

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter 71. Fluid and electrolyte issues in pediatric critical illness. Evans I, Joyce E. Page 866-872
  • Rogers' textbook of Pediatric Intensive Care Chapter 108: Disorders of Water, Sodium and Potassium homeostasis: Schneider J & Glater-Welt L. Pages 1868-1880
  • Harrison’s Principles of Internal Medicine Volume 1. Chapter 53: Fluid and Electrolyte Disturbances. Mount D. Pages 338-347

Cardiopulmonary Interactions (basics) in the PICU15 Jun 202500:28:40

Today, Dr. Rahul Damania, Dr. Pradip Kamat, and Dr. Monica Gray, pediatric intensivists, sit down to chat about the diagnosis and management of acute myocarditis in children. They focus on a real-life case involving a one-month-old infant who presented with poor feeding, respiratory distress, and fever. Together, they break down the possible causes, key clinical signs, diagnostic approaches, and treatment options for pediatric myocarditis. Throughout the discussion, they highlight the importance of early recognition, a multidisciplinary team approach, and supportive care in improving outcomes for these critically ill infants. This episode is packed with practical insights and is designed to help pediatric intensivists tackle this challenging and potentially life-threatening condition. Tune in to hear more!

Show Highlights:

  • Definition and etiology of acute myocarditis in pediatric patients
  • Clinical case presentation of a one-month-old infant with acute myocarditis
  • Symptoms and clinical manifestations of acute myocarditis in children
  • Diagnostic approaches for identifying acute myocarditis, including echocardiography and laboratory tests
  • Management strategies for acute myocarditis, including intensive care and medication
  • Importance of recognizing atypical presentations in infants
  • Prognosis and risk factors associated with acute myocarditis
  • Role of multidisciplinary collaboration in managing acute myocarditis
  • Impact of viral infections on the development and severity of myocarditis
  • Outcomes and potential complications related to acute myocarditis in pediatric patients

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter 108. Life-threatening viral diseases and their treatment. Vora S et al. Pages 1273-1278
  • Rogers’ textbook of Pediatric Intensive Care. Chapter 74: cardiomyopathy, myocarditis, and mechanical circulatory support. Harmon WG et al. Pages 1247-1255
  • Robinson J, Hartling L, Vandermeer B, Sebastianski M, Klassen TP. Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev. 2020 Aug 19;8(8): CD004370. Doi: 10.1002/14651858.CD004370.pub4. PMID: 32835416

Approach to Carbon Monoxide (CO) Poisoning in the PICU25 May 202500:22:57

In this episode of "PICU Doc on Call," pediatric intensivists Dr. Rahul Damania, Dr. Pradip Kamat, and Dr. Monica Gray discuss a critical case involving a 16-year-old male who experienced severe carbon monoxide poisoning after being found unresponsive in a garage. They chat about the pathophysiology, clinical manifestations, diagnostic workup, and management of carbon monoxide toxicity. Furthermore, they cover the importance of early oxygen administration, recognizing potential delayed neurological sequelae, and keeping an eye out for cardiac complications. Tune in and hear more about a comprehensive approach to treatment and the significance of multidisciplinary support for achieving the best patient outcomes.

Show Highlights:

  • Case presentation of a 16-year-old male with severe carbon monoxide poisoning
  • Pathophysiology of carbon monoxide toxicity and its effects on hemoglobin
  • Clinical manifestations and symptoms associated with carbon monoxide poisoning
  • Diagnostic workup for suspected carbon monoxide exposure
  • Management principles for treating carbon monoxide poisoning in pediatric patients
  • Sources and scenarios leading to carbon monoxide poisoning
  • Complications arising from carbon monoxide exposure including neurological injuries
  • Importance of early oxygen administration and monitoring in treatment
  • Discussion of hyperbaric oxygen therapy and its indications
  • Key takeaways for clinicians regarding the management and follow-up of carbon monoxide poisoning cases

We welcome you to share your feedback, subscribe & place a review on our podcast! Please visit our website picudoconcall.org.

References:

  • Tapking, C., et al. (2021). Burn and inhalation injury. In J. J. Zimmerman & A. T. Rotta (Eds.), Fuhrman and Zimmerman’s Pediatric Critical Care (6th ed., pp. 1347–1362). Elsevier.
  • Nañagas KA, Penfound SJ, Kao LW. Carbon Monoxide Toxicity. Emerg Med Clin North Am. 2022 May;40(2):283-312. doi: 10.1016/j.emc.2022.01.005. Epub 2022 Apr 5. PMID: 35461624.
  • Smollin C, Olson K. Carbon monoxide poisoning (acute). BMJ Clin Evid. 2010 Oct 12;2010:2103. PMID: 21418677; PMCID: PMC3217756.
  • Palmeri R, Gupta V. Carboxyhemoglobin Toxicity. [Updated 2023 Apr 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.

Oxygen Extraction Ratio (O₂ ER) in the PICU11 May 202500:25:26

Welcome to another exciting episode of PICU Doc on Call! Today, we're diving deep into the world of pediatric critical care with our expert hosts, Dr. Rahul Damania, Dr. Pradip Kamat, and Dr. Monica Gray. Get ready to unravel the mysteries of the oxygen extraction ratio (O2ER) and its pivotal role in managing pediatric acute respiratory distress syndrome (ARDS) and multi-organ dysfunction.

Picture this: a seven-year-old girl battling severe pneumonia that spirals into ARDS and septic shock. Our hosts walk you through this gripping case, shedding light on calculating O2ER and why central venous oxygen saturation (ScvO2) is a game-changer. They'll share their top strategies for optimizing oxygen delivery and cutting down on oxygen demand.

But that's not all! This episode is all about the holistic approach to managing critically ill pediatric patients. Tune in to discover how these insights can lead to better outcomes for our youngest and most vulnerable patients. Don't miss out on this vital conversation!

Show Highlights:

  • Clinical significance of the oxygen extraction ratio (O2ER) in pediatric critical care
  • Importance of understanding oxygen delivery and consumption in critically ill patients
  • Calculation and interpretation of O2ER and its relationship to central venous oxygen saturation (ScvO2)
  • Physiological concepts related to oxygenation, including intrapulmonary shunting and ventilation-perfusion mismatch
  • Management strategies for increasing oxygen delivery and reducing oxygen demand in ARDS and septic shock
  • Interventions such as blood transfusions, sedation, and optimization of cardiac output
  • Implications of lactic acidosis and anaerobic metabolism in the context of inadequate oxygen delivery
  • Holistic approach to patient management, focusing on both numerical values and overall metabolic needs

We welcome you to share your feedback, subscribe & place a review on our podcast! Please visit our website picudoconcall.org.

References:

  1. Fuhrman B.P. & Zimmerman J.J. (Eds.). Pediatric Critical Care, 6th ed. Elsevier; 2021. (Key concepts of oxygen delivery, consumption, and extraction in shock states are discussed in Chapter 13) .
  2. Nichols D.G. (Ed.). Roger’s Textbook of Pediatric Intensive Care, 5th ed. Wolters Kluwer; 2016. (Comprehensive review of oxygen transport and utilization in critically ill children, including ARDS and shock).
  3. Lucking S.E., Williams T.M., Chaten F.C., et al. Dependence of oxygen consumption on oxygen delivery in children with hyperdynamic septic shock and low oxygen extraction. Crit Care Med. 1990;18(12):1316–1319. doi:10.1097/00003246-199012000-00002.
  4. Ronco J.J., Fenwick J.C., Tweeddale M.G., et al. Pathologic dependence of oxygen consumption on oxygen delivery in acute respiratory failure. Chest. 1990;98(6):1463–1466. doi:10.1378/chest.98.6.1463 .
  5. Carcillo J.A., Davis A.L., Zaritsky A. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med. 2002;30(6):1365–1378. (ACCM guidelines emphasizing ScvO₂ targets in shock) .
  6. Emeriaud G, López-Fernández YM, Iyer NP, et al; PALICC-2 Group; PALISI Network. Executive summary of the second international guidelines for the diagnosis and management of pediatric ARDS (PALICC-2). Pediatr Crit Care Med. 2023;24(2):143–168. doi:10.1097/PCC.0000000000003147.

A Case of Pertussis in the PICU27 Apr 202500:34:06

In this episode, Dr. Rahul Damania, Dr. Pradip Kamat, and Dr. Monica Gray dive into a critical case involving a five-week-old baby facing acute respiratory failure due to pertussis. They chat about how this condition shows up, how it's diagnosed, and the best ways to manage it, especially considering the serious complications it can cause in infants, like pulmonary hypertension and the potential need for ECMO. The conversation underscores the importance of catching it early and providing supportive care, while also highlighting how crucial vaccination is in preventing pertussis. Tune in to learn how severe this disease can be and why staying alert in pediatric care is so important.

Show Highlights:

  • Clinical case of a five-week-old infant with acute respiratory failure and pertussis diagnosis
  • Epidemiology and public health impact of pertussis, including vaccination rates and outbreak patterns
  • Pathophysiology of pertussis and its effects on respiratory health, particularly in infants
  • Clinical presentation of pertussis, including stages of the disease and atypical symptoms in infants
  • Diagnostic approaches for pertussis, including laboratory findings and PCR testing
  • Management strategies for severe pertussis, including supportive care and antibiotic therapy
  • Potential complications associated with pertussis, especially in young infants
  • Differential diagnosis considerations for pertussis and distinguishing features from other infections
  • Importance of vaccination in preventing pertussis and reducing morbidity and mortality
  • ECMO as a treatment option for severe cases and its associated challenges, and outcomes

We welcome you to share your feedback, subscribe & place a review on our podcast! Please visit our website picudoconcall.org.

References:

  1. Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter and Rogers texbook of Pediatric intensive care -both do not have any Pertussis mentioned in their index.
  2. Rowlands HE, Goldman AP, Harrington K, Karimova A, Brierley J, Cross N, Skellett S, Peters MJ. Impact of rapid leukodepletion on the outcome of severe clinical pertussis in young infants. Pediatrics. 2010 Oct;126(4):e816-27. doi: 10.1542/peds.2009-2860. Epub 2010 Sep 6. PMID: 20819895.
  3. Lauria AM, Zabbo CP. Pertussis. [Updated 2022 Oct 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519008/
  4. Berger JT, Carcillo JA, Shanley TP, Wessel DL, Clark A, Holubkov R, Meert KL, Newth CJ, Berg RA, Heidemann S, Harrison R, Pollack M, Dalton H, Harvill E, Karanikas A, Liu T, Burr JS, Doctor A, Dean JM, Jenkins TL, Nicholson CE; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Collaborative Pediatric Critical Care Research Network (CPCCRN). Critical pertussis illness in children: a multicenter prospective cohort study. Pediatr Crit Care Med. 2013 May;14(4):356-65. doi: 10.1097/PCC.0b013e31828a70fe. PMID: 23548960; PMCID: PMC3885763.
  5. Cousin, V.L., Caula, C., Vignot, J. et al. Pertussis infection in critically ill infants: meta-analysis and validation of a mortality score. Crit Care 29, 71 (2025). https://doi.org/10.1186/s13054-025-05300-2
  6. Domico M, Ridout D, MacLaren G, Barbaro R, Annich G, Schlapbach LJ, Brown KL. Extracorporeal Membrane Oxygenation for Pertussis: Predictors of Outcome Including Pulmonary Hypertension and Leukodepletion. Pediatr Crit Care Med. 2018 Mar;19(3):254-261. doi: 10.1097/PCC.0000000000001454. PMID: 29319632.
  7. Centers for Disease Control: https://www.cdc.gov/schoolvaxview/data/index.html; https://www.cdc.gov/pertussis/php/surveillance/pertussis-incidence-by-age-group-and-year.html; https://www.cdc.gov/pertussis/media/pdfs/2025/01/pertuss-surv-report-2024_PROVISIONAL-508.pdf (various links)
  8. Tuan, Ta Anh MD, PhD1; Xoay, Tran Dang MD1; Nakajima, Noriko MD, PhD2; Nakagawa, Satoshi MD3; Phuc, Phan Huu MD, PhD1; Hung, Dau Viet MD, PhD1; Dung, Nguyen Trong MD1; Dong, Ngo Tien MD1; Dung, Tran Ba MD1; Thuy, Phung Thi Bich PhD4; Hai, Le Thanh MD, PhD5; Dien, Tran Minh MD, PhD6. Pertussis Infants Needing Mechanical Ventilation and Extracorporeal Membrane Oxygenation: Single-Center Retrospective Series in Vietnam. Pediatric Critical Care Medicine 22(9):p e471-e479, September 2021. | DOI: 10.1097/PCC.0000000000002723

Management of Upper Airway Obstruction | Croup in the PICU13 Apr 202500:32:34

In today’s episode, Dr. Rahul Damania and Dr. Pradip Kamat welcome their new co-host, Dr. Monica Gray. They’ll dive into the topic of upper airway obstruction in children and explore a case involving a 12-month-old girl who presents with stridor and fever. Throughout the discussion, they delve into the underlying causes, possible diagnoses, and management strategies. Key takeaways include the significance of keeping the child calm, ensuring proper positioning, and utilizing treatments such as dexamethasone and Racemic epinephrine. They’ll also touch on advanced therapies and serious infections like epiglottitis. The episode highlights the importance of recognizing stridor, knowing when to consider PICU admission, and the effectiveness of low-dose dexamethasone. Tune in to learn more!

Show Highlights:

  • Overview of upper airway obstruction in pediatric patients
  • Case presentation of a 12-month-old girl with stridor and fever
  • Discussion on the pathophysiology of stridor and its clinical significance
  • Differential diagnoses for stridor, including croup, epiglottitis, and foreign body aspiration
  • Management strategies for upper airway obstruction, including stabilization and medication
  • Importance of calming the child and optimal positioning during treatment
  • Use of dexamethasone and racemic epinephrine in managing croup
  • Advanced therapies, such as Helios, for specific cases
  • Indicators for pediatric intensive care unit (PICU) admission
  • Key clinical points and takeaways for healthcare professionals managing airway emergencies

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter 47 Otteson T, Richardson C, Shah J: Diseases of the upper Airway. Pages 524-535
  • Rogers Textbook of Pediatric Intensive Care: Chapter 25; Ong May Soo Jacqueline, Tijssen J, Bruins BB and Nishisaki A: Airway management. Pages 341-365
  • Reference: Asmundsson AS, Arms J, Kaila R, Roback MG, Theiler C, Davey CS, Louie JP. Hospital Course of Croup After Emergency Department Management. Hosp Pediatr. 2019 May;9(5):326-332. doi: 10.1542/hpeds.2018-0066. PMID: 30988017; PMCID: PMC6478427.
  • Reference: Aregbesola A, Tam CM, Kothari A, Le ML, Ragheb M, Klassen TP. Glucocorticoids for croup in children. Cochrane Database Syst Rev. 2023 Jan 10;1(1):CD001955. doi: 10.1002/14651858.CD001955.pub5. PMID: 36626194; PMCID: PMC9831289.

Previous Episode Mentioned:

PICU Doc On Call Episode 80

Measly Business - A Guide for the Pediatric Intensivist30 Mar 202500:30:38

In this episode of PICU DOC on Call, Dr. Rahul Damania and Dr. Pradip Kamat discuss the resurgence of measles in the United States. They explore the virus's pathophysiology, clinical features, diagnostic methods, treatment options, and complications. They emphasize the critical role of vaccination in preventing measles outbreaks and address the historical context and public health challenges related to vaccine hesitancy. The speakers highlight the severe complications of measles, especially in immunocompromised patients, and advocate for robust vaccination efforts to protect vulnerable populations and prevent the spread of this preventable disease. Tune in to hear more!

Show Highlights:

  • Resurgence of measles in the United States
  • Historical context of measles outbreaks and vaccination impact
  • Current statistics and recent cases of measles
  • Pathophysiology of the measles virus
  • Clinical features and progression of measles infection
  • Diagnostic approaches for confirming measles
  • Differential diagnosis considerations for fever and rash
  • Treatment options and the role of vaccination
  • Complications associated with measles, including severe outcomes
  • Public health challenges related to vaccine hesitancy and advocacy for immunization

Resources:

CDC Measles Info Page

WHO Measles Global Surveillance

References:

Fuhrman & Zimmerman. Textbook of Pediatric Critical Care, Ch. 52

Long S et al. Principles and Practice of Pediatric Infectious Diseases, Ch. 227

Moss WJ. Measles. Lancet. 2017;390(10111):2490-2502

Paules CI, Marston HD, Fauci AS. NEJM. 2019;380(23):2185-2187

Cardiopulmonary Interactions (basics) in the PICU09 Mar 202500:20:37

In this episode of PICU DOC on Call, Dr. Rahul Damania and Dr. Pradip Kamat chat about a challenging case involving a 15-year-old girl dealing with acute myocarditis and worsening respiratory failure. They explore the intricate dance between the heart and lungs, especially how positive pressure ventilation can affect heart function. They cover important topics like cardiac output, preload, and afterload, and discuss the delicate balance needed to manage myocarditis effectively. The episode offers practical tips for optimizing care for critically ill children, underscoring the importance of personalized treatment plans and teamwork in pediatric critical care. Tune in!

Show Highlights:

  • Clinical case of a 15-year-old girl with acute myocarditis and respiratory failure
  • Importance of understanding cardiopulmonary interactions in pediatric critical care
  • Effects of positive pressure ventilation on cardiac function
  • Key concepts of cardiac output, preload, and afterload in the context of myocarditis
  • Challenges of managing hemodynamic instability in critically ill pediatric patients
  • Differences between spontaneous breathing and positive pressure ventilation
  • Strategies for optimizing preload and fluid management in myocarditis patients
  • Tailoring ventilatory support and transitioning to invasive mechanical ventilation
  • Monitoring for arrhythmias and managing myocardial function with inotropic support
  • Importance of frequent assessments and collaboration with cardiac ICU teams for patient care

Management Strategies

Optimizing Preload:

  • Volume depletion is common in patients with hypotension and tachycardia. A careful fluid challenge is important to restore circulatory volume, but fluid overload should be avoided, especially with impaired left ventricular function.

Tailoring Ventilatory Support:

  • Adjust BiPAP settings to improve oxygenation without overloading the heart with excessive positive pressures.
  • Use the optimal level of PEEP to recruit alveoli while maintaining adequate venous return to the heart.

Supporting Myocardial Function:

  • Inotropic support (e.g., milrinone) may be necessary to improve myocardial contractility. Milrinone also provides vasodilation, which can reduce afterload but must be used cautiously due to its potential to lower blood pressure.

Frequent Reassessments:

  • Bedside echocardiography and regular monitoring of biomarkers (lactate, BNP) and clinical status are essential for ongoing evaluation.
  • In severe cases, advanced therapies like ECMO may be required if the patient’s hemodynamic status continues to deteriorate.


Traumatic Brain Injury in the PICU | Non-Neurological Organ Dysfunction (NNOD)12 Jan 202500:30:27

Today,  pediatric intensivists Dr. Pradip Kamat and Dr. Rahul Damania discuss a complex case of a 12-year-old girl who suffered a seizure and unresponsiveness due to a subarachnoid hemorrhage from a ruptured aneurysm. They explore the multi-system effects of traumatic brain injury (TBI) and intracranial hemorrhage, focusing on non-neurologic organ dysfunction.

They’ll also highlight the impact on cardiovascular, respiratory, renal, and hepatic systems, emphasizing the importance of understanding these interactions for better patient management.

Tune in to hear relevant studies and management strategies to improve outcomes in pediatric TBI cases.

In This Episode:

  • Clinical case of a 12-year-old girl with seizure and unresponsiveness due to subarachnoid hemorrhage from a ruptured aneurysm
  • Management of non-neurologic organ dysfunction in traumatic brain injury (TBI) and intracranial hemorrhage
  • Multi-system effects of brain injuries, including cardiovascular, respiratory, renal, and hepatic complications
  • Importance of recognizing non-neurologic organ dysfunction in pediatric patients
  • Epidemiology and prevalence of non-neurologic organ dysfunction in patients with aneurysms or subarachnoid hemorrhage
  • Mechanisms of organ dysfunction following brain injury, including inflammatory responses and cytokine release
  • Management strategies for cardiovascular complications in TBI patients.
  • Discussion of respiratory complications, such as acute lung injury and ARDS, in the context of TBI
  • Renal and hepatic dysfunction associated with traumatic brain injury and their management
  • Emphasis on the need for a comprehensive understanding of organ interactions to improve patient outcomes in pediatric critical care

Conclusion

In summary, the episode underscores the complex interplay between brain injury and multi-system organ dysfunction. The hosts emphasize the need for a comprehensive understanding of these interactions to improve patient outcomes in pediatric TBI cases. They advocate for a team-based approach to management, focusing on individual patient physiology and the delicate balance required to address the challenges posed by non-neurologic organ dysfunction.

Connect With Us!

We hope you found value in this case-based discussion. Please share your feedback, subscribe, and leave a review on our podcast. For more resources, visit our website at PICUoncall.org.

Thank you for joining us, and stay tuned for our next episode!




Little Lungs Big Bugs: Approach to Bacterial PNA05 Jan 202500:26:25

Welcome to another insightful episode of PICU on Call, a podcast dedicated to current and aspiring intensivists. In this episode, our hosts, Dr. Pradip Kamat, Dr. Rahul Damania, and their colleague, Dr. Jordan Dent, delve into the complexities of managing pneumonia in pediatric patients. The discussion is anchored around a clinical case involving a 10-year-old girl presenting with difficulty breathing and a fever, suggestive of pneumonia. We will break down the key themes and insights from the case, providing a comprehensive guide to understanding and managing pediatric pneumonia.

Case Presentation

The episode begins with a detailed case presentation:

  • Patient: 10-year-old girl, 28-week preemie with chronic lung disease.
  • Symptoms: Progressive respiratory distress over eight days, worsening cough, increased work of breathing, hypoxemia (oxygen saturation in the low 80s despite supplemental oxygen).
  • Findings: Chest X-ray reveals bilateral lower lobe infiltrates and a left-sided pleural effusion. Lab results show elevated CRP and a positive respiratory PCR for a bacterial pathogen.

This case sets the stage for an in-depth discussion on the various aspects of pediatric pneumoRisk Factors for Pneumonia

Understanding the risk factors for pneumonia is crucial for early identification and prevention.

These risk factors can be categorized into three main groups:

Host Factors

  • Incomplete Immunization Status: Children who are not fully vaccinated are at higher risk
  • Young Age: Infants and young children have immature immune systems, making them more susceptible
  • Lower Socioeconomic Status: Limited access to healthcare and poor living conditions can increase risk

Environmental Factors

  • Exposure to Tobacco Smoke: Secondhand smoke can damage the respiratory tract and impair immune function
  • Seasonal Variations: Pneumonia cases peak during fall and winter due to increased circulation of respiratory viruses
  • Contact with Other Children: Daycare settings and schools can facilitate the spread of infections

Healthcare-Associated Factors

  • Prolonged Mechanical Ventilation: Increases the risk of ventilator-associated pneumonia (VAP)
  • Nasogastric Tube Placement: Can introduce pathogens into the respiratory tract.
  • Neuromuscular Blockade: Impairs the ability to clear secretions
  • Inadequate Humidification: Dry air can damage the respiratory mucosa

Pathogenesis of Pneumonia

Pneumonia occurs when pathogens invade the lower respiratory tract, triggering an inflammatory response. This leads to fluid accumulation and white blood cell infiltration in the alveoli, resulting in:

  • Decreased Lung Compliance: The lungs become stiffer and harder to expand.
  • Increased Airway Resistance: Narrowing of the airways makes breathing more difficult.
  • Ventilation-Perfusion (V/Q) Mismatch: Impaired gas exchange leads to hypoxia and tachypnea.

Etiology by Age Group

The causative pathogens of pneumonia vary by age group:

  • Neonates: Group B Streptococcus, E. coli, Listeria, Klebsiella
  • Children Under 5: Viral causes (50% of cases) such as RSV, human metapneumovirus, and influenza, with bacterial causes like Streptococcus pneumoniae and Haemophilus influenzae
  • Older Children and Teens: Mycoplasma pneumonia, Chlamydia pneumonia, and Streptococcus pneumoniae

Classification of Pneumonia

Pneumonia can be classified based on the acquisition setting:

  • Community-Acquired Pneumonia (CAP): Occurs in patients not hospitalized in the past month
  • Hospital-Acquired Pneumonia (HAP): Develops after 48 hours of hospitalization
  • Ventilator-Associated Pneumonia (VAP): Occurs within 48 hours of intubation
  • Aspiration Pneumonia: Results from inhaling gastric or oral contents
  • Necrotizing Pneumonia: Caused by aggressive bacteria, often requiring CT imaging for diagnosis

Clinical Presentation

When a child presents with suspected pneumonia, clinicians should look for:

  • Systemic Symptoms: Fever, lethargy, poor appetite
  • Respiratory Symptoms: Tachypnea, hypoxia, and classic findings like crackles
  • Key Indicators: Moderate hypoxemia (SpO2 < 96%) and increased respiratory effort (nasal flaring, intercostal retractions)

Diagnostic Approach

The diagnostic workup for bacterial pneumonia typically includes:

  • Basic Labs: CBC, inflammatory markers (CRP, procalcitonin), and a comprehensive metabolic panel
  • Cultures: Blood cultures have low yield; pleural fluid cultures are more definitive
  • Imaging: Chest X-rays can overestimate pneumonia; point-of-care ultrasound may help identify effusions

Management Framework

Management begins with assessing whether the child can be treated at home or requires hospitalization. Key considerations for admission include:

  • Hypoxemia: SpO2 < 92%
  • Rapid Respiratory Rates: Indicative of severe respiratory distress
  • Toxic Appearance or Poor Oral Intake: Suggests a need for closer monitoring and supportive care

In the PICU, management involves:

Respiratory Support

  • Nasal Cannula: For mild cases
  • High-Flow Nasal Cannula (HFNC): For moderate cases
  • Mechanical Ventilation: For severe cases of respiratory failure

Antibiotic Therapy

  • Empiric Therapy: Based on age, severity, and local resistance patterns
  • Targeted Therapy: Adjusted based on culture results and clinical response

Supportive Care

  • Fluid Management: To maintain hydration and electrolyte balance
  • Nutrition: Ensuring adequate caloric intake
  • Fever Control: Using antipyretics to manage fever

Complications of Pneumonia

Complications occur in about 3% of pneumonia cases and include:

  • Pleural Effusion: Managed with chest tube placement and fibrinolytic therapy
  • Necrotizing Pneumonia: May require drainage if abscesses develop
  • Systemic Complications: Such as ARDS, sepsis, and multi-organ dysfunction

Conclusion

Early diagnosis and management of bacterial pneumonia are crucial to prevent complications and mortality. Key indicators include moderate hypoxemia and increased work of breathing. Diagnostic imaging findings such as large pleural effusions and cavitation strongly suggest bacterial infection.

Inhalation Injury in the PICU22 Dec 202400:22:44

In today’s episode, we explore a tragic but educational case involving a 15-year-old girl who suffered severe inhalation injury following a house fire. While heroically rescuing her brother and his friend, she endured prolonged cardiac arrest and severe multi-organ dysfunction. We’ll focus on the pathophysiology, investigation, and management of inhalation injuries, including the critical role of recognizing carbon monoxide and cyanide poisoning in these complex cases.

Key Learning Points:

  • Exposure to house fire and prolonged cardiac arrest
  • Signs of inhalation injury and airway compromise
  • Pathophysiology of inhalation injuries and their impact on multiple organ systems
  • Management strategies for inhalation injury, including airway protection and ventilation
  • Differentiating carbon monoxide and cyanide poisoning in pediatric fire victims

Case Presentation

A 15-year-old previously healthy girl is brought to the Pediatric Intensive Care Unit (PICU) after experiencing cardiac arrest during a house fire. She was found unconscious by firefighters after a heroic rescue attempt where she saved her brother and his friend. Upon arrival at the hospital, she was unresponsive, intubated, and in severe cardiovascular distress with signs of multi-organ dysfunction.

Key findings include:

  • Soot deposits and superficial burns on extremities
  • Prolonged resuscitation (45 minutes of field CPR and 47 minutes of in-hospital CPR)
  • Cardiovascular compromise with PVCs, cool extremities, and delayed capillary refill
  • Metabolic acidosis, AKI, coagulopathy, transaminitis
  • Severe hypoxic-ischemic encephalopathy on EEG

These findings raise immediate concern for inhalation injury, which is the primary focus of today's discussion.

Pathophysiology of Inhalation Injury

When a patient is exposed to smoke and hot gases during a fire, inhalation injury results in significant damage to the respiratory system. Inhalation injury has three main components:

  1. Upper airway involvement – Thermal injury can cause swelling and obstruction.
  2. Chemical pneumonitis – Noxious chemicals like carbon monoxide and cyanide trigger inflammation in the lungs.
  3. Systemic toxicity – Toxins such as carbon monoxide and cyanide can affect cellular oxygen utilization.

The primary damage occurs in the lower respiratory tract, leading to airway edema, mucosal damage, and bronchial cast formation. This process can result in bacterial pneumonia, respiratory failure, and the need for aggressive intervention.

Investigating Inhalation Injury

A thorough diagnostic approach is essential when assessing patients with suspected inhalation injury:

  1. Basic Imaging: A chest X-ray (CXR) should be obtained, although a normal film doesn't rule out injury.
  2. Gold Standard – Bronchoscopy: Direct visualization allows for assessment and removal of bronchial casts.
  3. Laboratory Tests: Key labs include CBC, CMP, blood gas, lactate, co-oximetry (to assess CO levels), and toxicology screens.
  4. CO and Cyanide Testing: Critical for identifying toxic exposure, especially when a patient presents with altered mental status or unexplained metabolic acidosis.

Managing Inhalation Injury: A Structured Approach

Management revolves around three key pillars:

  1. Airway Protection: Intubation is essential for airway security. Signs such as progressive hoarseness, soot around the nose, or face burns should prompt early intervention.
  2. Ventilation Strategies: Use low tidal volumes and optimized PEEP for lung protection. In severe cases, consider advanced modalities like APRV, HFOV, or ECMO.
  3. Secretion Management: Aggressive pulmonary toilet and medications such as nebulized heparin, tPA, and N-acetylcysteine may help manage airway inflammation and obstructions.

Recognizing and Treating Carbon Monoxide (CO) Poisoning

In cases of suspected CO poisoning, the key is early recognition and treatment:

  • CO Blood Levels: Measure carboxyhemoglobin levels immediately.
  • Classic Symptoms: Look for the “cherry red” skin color and neurologic symptoms such as confusion or dizziness.
  • First-Line Therapy: Administer 100% oxygen via a non-rebreather mask or endotracheal tube.
  • Hyperbaric Oxygen: While 100% O2 works well, HBO therapy is crucial for preventing delayed neuropsychiatric complications.

Fun Fact: CO has a much higher affinity for hemoglobin than oxygen, which leads to a "tissue oxygen famine," even with normal PaO2 levels.

Identifying Cyanide Poisoning in Fire Victims

Cyanide poisoning can be particularly challenging to diagnose but is crucial in fire victims. Look for:

  • Classic Triad: Metabolic acidosis, elevated venous oxygen saturation, and CNS symptoms (confusion, mydriasis).
  • Late Signs: Cardiovascular collapse, hypotension, and bradycardia.
  • Treatment: Hydroxocobalamin is the first-line antidote (70 mg/kg IV), with the caveat that purple-red urine is a normal side effect.
  • Avoid Nitrites: In burn victims, nitrite-based cyanide kits can worsen CO poisoning by forming methemoglobin.

Clinical Tip: Unlike CO poisoning, cyanide poisoning presents with seizures and dilated pupils.

Clinical Course of Our Patient

The patient’s clinical course was marked by rapid deterioration despite aggressive treatment:

  • Initially managed with high-frequency oscillatory ventilation (HFOV) due to pulmonary hemorrhage
  • Developed severe PARDS, cardiac dysfunction, and multi-organ failure within 12 hours
  • Ultimately, neuroimaging revealed anoxic brain injury with cerebral edema and herniation, leading to brain death

This heartbreaking case highlights the importance of early intervention and recognition of inhalation...

Approach Toxic Alcohol Ingestion in the PICU15 Dec 202400:30:06
Welcome and Episode Introduction
  • Hosts: Dr. Pradip Kamat (Children’s Healthcare of Atlanta/Emory University) and Dr. Rahul Damania (Cleveland Clinic Children’s Hospital)
  • Mission: A podcast dedicated to current and aspiring pediatric intensivists, exploring intriguing PICU cases and acute care pediatric management
  • Focus of the Episode: Managing toxic alcohol ingestion in the PICU with emphasis on ethanol, methanol, ethylene glycol, propylene glycol, and isopropyl alcohol

Case Presentation
  • Patient Details: A 7-month-old male presented with accidental ethanol ingestion after his formula was mixed with vodka
  • Key Symptoms: Lethargy, uncoordinated movements, decreased activity, and ethanol odor
  • Initial Labs & Findings:
  • EtOH level: 420 mg/dL.
  • Glucose: 50 mg/dL.
  • Normal CXR and EKG.
  • PICU Presentation: Tachycardic, normotensive, lethargic, with signs of CNS depression
  • Initial Management: Dextrose infusion, glucose monitoring, neurological observation, and ruling out complications

Key Learning Points from the Case
  • Toxic alcohol ingestion in pediatrics requires rapid stabilization and targeted interventions
  • Hypoglycemia and CNS depression are common features of ethanol toxicity in infants
  • Management prioritizes glucose correction, airway support, and close neurological monitoring

Deep Dive: Toxic Alcohols in the PICU

1. Ethanol

  • Typical Presentation in Infants/Toddlers: Hypotonia, ataxia, coma, hypoglycemia, hypotension, and hypothermia
  • Diagnostic Workup:
  • Focus on CNS and metabolic effects
  • Labs: Glucose, electrolytes, bicarbonate, anion gap, ketones, toxicology screen
  • Imaging (head CT) if indicated
  • Management: Stabilization, IV dextrose for hypoglycemia, NPO status until alert, and consultation with poison control and social work

2. Methanol

  • Sources: Windshield fluids, cleaning agents, moonshine

Clinical Stages:

  1. Early: Dizziness, nausea, vomiting (0–6 hours)
  2. Latent: Asymptomatic (6–30 hours)
  3. Late: Vision disturbances, seizures, respiratory failure (6–72 hours)

  • Key Symptoms: “Snowstorm blindness” from retinal toxicity
  • Management: Fomepizole, correction of metabolic acidosis, and hemodialysis in severe cases

3. Ethylene Glycol

  • Sources: Antifreeze, brake fluids, household cleaners
  • Pathophysiology: Metabolism to glycolic acid (acidosis) and oxalic acid (renal failure due to calcium oxalate crystals)
  • Red Flags: Hypocalcemia, renal failure, QT prolongation
  • Management: Fomepizole, supportive care, and hemodialysis for severe toxicity

4. Propylene Glycol

  • Sources: Medications like lorazepam and pentobarbital
  • Presentation: High anion gap metabolic acidosis at high doses, with renal and liver dysfunction
  • Management: Discontinue offending agent, supportive care, and hemodialysis if severe

5. Isopropyl Alcohol

  • Sources: Disinfectants, hand sanitizers
  • Presentation: CNS depression, GI irritation, fruity acetone breath, but no metabolic acidosis
  • Management: Supportive care; fomepizole and ethanol are ineffective

Key Laboratory Insights
  • Osmolar Gap Formula:
  • Measured Osmolality - Calculated Osmolality
  • A high osmolar gap indicates unmeasured osmoles like toxic alcohols.
  • Lactate Gap in Ethylene Glycol: Discrepancy between bedside and lab lactate levels due to glycolate interference

Management Pearls
  • Ethanol and Ethylene Glycol: Fomepizole as first-line treatment; hemodialysis for severe cases
  • Methanol: Similar approach with additional focus on preventing blindness
  • Propylene Glycol: Monitor lactate and renal function, discontinue offending medications
  • Isopropyl Alcohol: Supportive care, no acidosis present

Mnemonics for Toxic Alcohols

MEGA GAP:

  • Methanol and Ethylene Glycol: Anion Gap Acidosis with elevated Osmolar Gap
  • Isopropyl Alcohol: Isolated Osmolar Gap (no acidosis)
  • Propylene Glycol: Mimics ethylene glycol with HAGMA at high doses

Takeaway Messages
  • Early recognition of toxic alcohol ingestion is critical for successful management
  • Differentiate between toxic alcohols using anion gap, osmolar gap, and clinical presentation
  • Engage poison control and social work early in the process

Conclusion
  • Pediatric toxic alcohol ingestions are rare but potentially life-threatening
  • Fomepizole is a cornerstone therapy for methanol and ethylene glycol toxicity
  • Supportive care remains essential across all toxic alcohol ingestions

Connect with US!


Multisystem Organ Dysfunction Syndrome (MODS) in the PICU24 Nov 202400:32:14

Did you know that Multi-Organ Dysfunction Syndrome (MODS) can result from both infectious and non-infectious causes? In our latest episode, we delve deep into the pathophysiology of MODS, exploring how different organs interact and fail in sequence. We discuss key concepts like organ functional reserve and the kinetics of organ injury, which aren’t as straightforward as they seem. Tune in to learn about the non-linear progression of organ damage and how it impacts management strategies in pediatric critical care.

We break down the case into key elements:

  1. Patient Background: A 15-year-old girl with chronic TPN dependence and a PICC line presented with septic shock and respiratory failure.
  2. Initial Presentation: Blood cultures confirmed Gram-negative rod bacteremia. She developed multi-system complications, including acute kidney injury (AKI), thrombocytopenia, and cardiac dysfunction.
  3. Management: Broad-spectrum antibiotics, mechanical ventilation, vasoactive agents, and supportive care for MODS.

Key Case Highlights:
  • Clinical case of a 15-year-old girl with sepsis from a gram-negative rod
  • Dependence on total parenteral nutrition (TPN) and prolonged PICC line use
  • Discussion of septic shock, acute respiratory failure, and acute kidney injury
  • Overview of multiple organ dysfunction syndrome (MODS) and its definitions
  • Pathophysiology of MODS, including organ functional reserve and kinetics of organ injury
  • Molecular mechanisms involved in MODS, such as mitochondrial dysfunction and immune responses
  • Specific phenotypes of sepsis-induced MODS, including TAMOF and IPMOF
  • Management strategies for MODS, emphasizing multidisciplinary approaches
  • Role and complications of therapeutic plasma exchange (TPE) in treating MODS
  • Importance of recognizing signs of MODS and timely intervention in pediatric patients

Segment 1: MODS Definitions and Phenotypes
  • Key Definition: MODS is the progressive failure of two or more organ systems due to systemic insults (infectious or non-infectious).
  • Phenotypes:
  • TAMOF (Thrombocytopenia-Associated Multi-Organ Failure): Characterized by thrombocytopenia, hemolysis, and decreased ADAMTS13 activity.
  • Immunoparalysis: Persistent immunosuppression and risk of secondary infections.
  • Sequential Liver Failure: Often associated with viral triggers.

Segment 2: Pathophysiology of MODS

Molecular Insights:

  • Mitochondrial dysfunction and damage-associated molecular patterns (DAMPs)
  • Innate and adaptive immune dysregulation
  • Microcirculatory dysfunction and ischemia-reperfusion injury
  • Organ Interactions: MODS evolves through complex multi-organ interdependencies

Segment 3: Diagnosis and Evidence-Based Management
  • Key Diagnostic Pearls:
  • MODS is not solely infection-driven; it requires a shared mechanism and predictable outcomes.
  • Use biomarkers like ADAMTS13 and TNF-α response for phenotypic classification.
  • Management Highlights:
  • Supportive Care: Multisystem approach including lung-protective ventilation, renal replacement therapy, and hemodynamic support.
  • Therapeutic Plasma Exchange (TPE): Especially effective in TAMOF by restoring ADAMTS13 and removing inflammatory mediators.

Segment 4: Practical Tips for Intensivists
  • Early recognition of MODS phenotypes for targeted therapy
  • Importance of multidisciplinary teamwork in critical care settings
  • Monitoring for complications like TMA and immunoparalysis during prolonged ICU stays

Follow Us:





Acute Hydrocephalus in the PICU17 Nov 202400:36:16

In this episode, we discuss the case of a 15-year-old girl who presents with progressive headache, nausea, vomiting, and difficulty ambulating. Her condition rapidly evolves into altered mental status and severe hydrocephalus, leading to a compelling discussion about the evaluation, diagnosis, and management of hydrocephalus in pediatric patients.

We break down the case into key elements:

  • A comprehensive look at acute hydrocephalus, including its pathophysiology and causes
  • Epidemiological insights, clinical presentation, and diagnostic approaches
  • Management strategies, including temporary and permanent CSF diversion techniques
  • A review of complications related to shunts and endoscopic third ventriculostomy

Key Case Highlights:
  • Patient Presentation:
  • A 15-year-old girl with a 3-day history of worsening headaches, nausea, vomiting, and difficulty walking
  • Altered mental status and bradycardia upon PICU admission
  • CT scan revealed severe hydrocephalus without a clear mass lesion
  • Management Steps in the PICU:
  • Hypertonic saline bolus improved her mental status and pupillary reactions
  • Neurosurgery consultation recommended MRI and close neuro checks
  • Initial management included dexamethasone, keeping the patient NPO, and hourly neuro assessments
  • Differential Diagnosis:
  • Obstructive (non-communicating) vs. non-obstructive (communicating) hydrocephalus
  • Consideration of alternative diagnoses like intracranial hemorrhage and idiopathic intracranial hypertension

Episode Learning Points:
  • Hydrocephalus Overview:
  • Abnormal CSF buildup in the ventricles leading to increased intracranial pressure (ICP)
  • Key distinctions between obstructive and non-obstructive types

Epidemiology and Risk Factors:

  • Congenital causes include genetic syndromes, neural tube defects, and Chiari malformations
  • Acquired causes: post-hemorrhagic hydrocephalus (e.g., from IVH in preemies), infections like TB meningitis, and brain tumors

Clinical Presentation:

  • Infants: Bulging fontanelles, sunsetting eyes, irritability
  • Older children: Headaches, vomiting, papilledema, and gait disturbances

Management Framework:

  • Temporary CSF diversion via external ventricular drains (EVD) or lumbar catheters
  • Permanent interventions include VP shunts and endoscopic third ventriculostomy (ETV)

Complications of Shunts and ETV:

  • Shunt infections, malfunctions, over-drainage, and migration
  • ETV-specific risks, including delayed failure years post-procedure

Clinical Pearl:

  • Communicating hydrocephalus involves symmetric ventricular enlargement and is often linked to inflammatory or post-treatment changes affecting CSF reabsorption.

Hosts’ Takeaway Points:

  • Dr. Pradip Kamat emphasizes the importance of timely recognition and intervention in hydrocephalus to prevent complications like brain herniation.
  • Dr. Rahul Damania highlights the need for meticulous neurological checks in PICU patients and an individualized approach to treatment.

Resources Mentioned:
  • Hydrocephalus Clinical Research Network guidelines.
  • Recent studies on ETV outcomes in pediatric populations.

Call to Action:

If you enjoyed this discussion, please subscribe to PICU Doc On Call and leave a review. Have a topic you’d like us to cover? Reach out to us via email or on social media!

Follow Us:


Stay tuned for more cases that challenge and inspire us as PICU clinicians!

Approach Toxic Alcohol Ingestion in the PICU15 Oct 202400:30:06
Introduction
  • Hosts: Dr. Pradip Kamat (Children’s Healthcare of Atlanta/Emory University) and Dr. Rahul Damania (Cleveland Clinic Children’s Hospital)
  • Mission: A podcast dedicated to current and aspiring pediatric intensivists, exploring intriguing PICU cases and acute care pediatric management
  • Focus of the Episode: Managing toxic alcohol ingestion in the PICU with emphasis on ethanol, methanol, ethylene glycol, propylene glycol, and isopropyl alcohol

Case Presentation
  • Patient Details: A 7-month-old male presented with accidental ethanol ingestion after his formula was mixed with vodka
  • Key Symptoms: Lethargy, uncoordinated movements, decreased activity, and ethanol odor
  • Initial Labs & Findings:
  • EtOH level: 420 mg/dL.
  • Glucose: 50 mg/dL.
  • Normal CXR and EKG.
  • PICU Presentation: Tachycardic, normotensive, lethargic, with signs of CNS depression
  • Initial Management: Dextrose infusion, glucose monitoring, neurological observation, and ruling out complications

Key Learning Points from the Case
  • Toxic alcohol ingestion in pediatrics requires rapid stabilization and targeted interventions
  • Hypoglycemia and CNS depression are common features of ethanol toxicity in infants
  • Management prioritizes glucose correction, airway support, and close neurological monitoring

Deep Dive: Toxic Alcohols in the PICU

1. Ethanol

  • Typical Presentation in Infants/Toddlers: Hypotonia, ataxia, coma, hypoglycemia, hypotension, and hypothermia
  • Diagnostic Workup:
  • Focus on CNS and metabolic effects
  • Labs: Glucose, electrolytes, bicarbonate, anion gap, ketones, toxicology screen
  • Imaging (head CT) if indicated
  • Management: Stabilization, IV dextrose for hypoglycemia, NPO status until alert, and consultation with poison control and social work

2. Methanol

  • Sources: Windshield fluids, cleaning agents, moonshine
  • Clinical Stages:

  1. Early: Dizziness, nausea, vomiting (0–6 hours)
  2. Latent: Asymptomatic (6–30 hours)
  3. Late: Vision disturbances, seizures, respiratory failure (6–72 hours)

  • Key Symptoms: “Snowstorm blindness” from retinal toxicity
  • Management: Fomepizole, correction of metabolic acidosis, and hemodialysis in severe cases

3. Ethylene Glycol

  • Sources: Antifreeze, brake fluids, household cleaners
  • Pathophysiology: Metabolism to glycolic acid (acidosis) and oxalic acid (renal failure due to calcium oxalate crystals)
  • Red Flags: Hypocalcemia, renal failure, QT prolongation
  • Management: Fomepizole, supportive care, and hemodialysis for severe toxicity

4. Propylene Glycol

  • Sources: Medications like lorazepam and pentobarbital
  • Presentation: High anion gap metabolic acidosis at high doses, with renal and liver dysfunction
  • Management: Discontinue offending agent, supportive care, and hemodialysis if severe

5. Isopropyl Alcohol

  • Sources: Disinfectants, hand sanitizers
  • Presentation: CNS depression, GI irritation, fruity acetone breath, but no metabolic acidosis
  • Management: Supportive care; fomepizole and ethanol are ineffective

Key Laboratory Insights
  • Osmolar Gap Formula:
  • Measured Osmolality - Calculated Osmolality
  • A high osmolar gap indicates unmeasured osmoles like toxic alcohols.
  • Lactate Gap in Ethylene Glycol: Discrepancy between bedside and lab lactate levels due to glycolate interference

Management Pearls
  • Ethanol and Ethylene Glycol: Fomepizole as first-line treatment; hemodialysis for severe cases
  • Methanol: Similar approach with additional focus on preventing blindness
  • Propylene Glycol: Monitor lactate and renal function, discontinue offending medications
  • Isopropyl Alcohol: Supportive care, no acidosis present

Mnemonics for Toxic Alcohols

MEGA GAP:

  • Methanol and Ethylene Glycol: Anion Gap Acidosis with elevated Osmolar Gap
  • Isopropyl Alcohol: Isolated Osmolar Gap (no acidosis)
  • Propylene Glycol: Mimics ethylene glycol with HAGMA at high doses

Takeaway Messages
  • Early recognition of toxic alcohol ingestion is critical for successful management
  • Differentiate between toxic alcohols using anion gap, osmolar gap, and clinical presentation
  • Engage poison control and social work early in the process

Conclusion
  • Pediatric toxic alcohol ingestions are rare but potentially life-threatening
  • Fomepizole is a cornerstone therapy for methanol and ethylene glycol toxicity
  • Supportive care remains essential across all toxic alcohol ingestions

Connect with US!

Twitter: @PICUDocOnCall

Email: contact@picudoconcall.com





It’s Getting Hot in Here | Heat Stroke in the PICU13 Oct 202400:29:35
Introduction:

Today, Dr. Rahul Damania, Dr. Pradip Kamat, and their guest,  Dr. Jordan Dent, discuss a critical case involving a 15-year-old male who collapsed during football practice due to exertional heat stroke. The discussion emphasizes the clinical presentation, risk factors, pathophysiology, and evidence-based management of heat stroke and other heat-related illnesses in pediatric patients. The episode also delves into the role of rapid cooling interventions and long-term care to minimize mortality and morbidity.

Case Summary: A 15-year-old male with ADHD collapsed during football practice on a hot, humid day. He presented with:

  • Normotension (BP: 101/67 mmHg)
  • Tachycardia (HR: 157 bpm)
  • Tachypnea (RR: 40 breaths/min)
  • Febrile (Rectal temp: 41.8°C/107.2°F)
  • Dry, hot skin, GCS of 9
  • Lab abnormalities: hyponatremia, hypokalemia, hypoglycemia, elevated creatinine, liver enzymes, lactate, CK, and troponin

After suffering cardiac arrest and undergoing resuscitation, the patient developed multiorgan dysfunction, including seizures, encephalopathy, and cerebral edema. Despite severe initial complications, the patient demonstrated neurological improvement with left-side hemiparesis before discharge.

Key Discussion Points:

  1. Etiology and Pathophysiology of Heat Stroke:

  • Heat stroke occurs when the body’s thermoregulatory mechanisms fail, leading to dangerous elevations in core body temperature. Exertional heat stroke is common during strenuous physical activity in hot, humid environments.
  • Key physiological breakdowns include inadequate sweating, vasodilation dysfunction, and subsequent cellular damage due to hyperthermia.

  1. Risk Factors for Exertional Heat Stroke:

  • Environmental factors: High temperature, humidity, lack of hydration, and breaks.
  • Athlete-related factors: Hypohidrosis, dehydration, medical conditions, and medications (e.g., Adderall).
  • Heat illness is the third leading cause of death in high school athletics, with American football players particularly at risk.

  1. Spectrum of Heat-Related Illness:

  • Heat Cramps: Involuntary muscle contractions due to dehydration and electrolyte imbalance.
  • Heat Syncope: Transient loss of consciousness due to heat exposure.
  • Heat Exhaustion: Milder heat illness with core temperature < 104°F, potentially progressing to heat stroke if untreated.
  • Heat Stroke: Life-threatening with core temperature ≥ 104°F, CNS dysfunction, and risk of multiorgan failure.

  1. Management of Heat Stroke:

  • Rapid Cooling: Immediate cooling to bring core temperature down to 39°C within 30 minutes is critical. Methods include ice packs, cold water immersion, and core cooling techniques (cold IV fluids, gastric lavage).
  • Supportive Care: Management of shock, electrolyte imbalances, rhabdomyolysis, DIC, and ARDS.
  • Monitoring and Long-Term Care: Continuous EEG, fluid management, and rehabilitation are key in managing neurological and systemic complications.

  1. Differentiating Heat Stroke from Fever:

  • Fever results from a reset of the hypothalamic setpoint due to pyrogens, while heat stroke involves the failure of thermoregulation without a change in the hypothalamic setpoint.

  1. Case Outcome:

  • The patient initially suffered significant neurological damage but improved with intensive care and rehabilitation. By discharge, the patient showed notable recovery, though with some lasting deficits.

Key Takeaways:

  1. Heat stroke is a medical emergency with a high risk of mortality and long-term complications if not treated promptly.
  2. Early recognition, rapid cooling, and a multidisciplinary approach are critical to improving outcomes.
  3. Athletes and children engaging in strenuous activities in hot environments should be closely monitored for signs of heat-related illness.

References:

  1. Fuhrman, B., & Zimmerman, J. J. (2020). Hyperthermic Injury. In Textbook of Pediatric Critical Care (pp. 1327-1331).
  2. Rogers, M. C., et al. (2016). Thermoregulation. In Rogers' Textbook of Pediatric Intensive Care (pp. 546-552).
  3. Ishimine, P. (2022). Heat Stroke in Children. UpToDate. Retrieved from www.uptodate.com/contents/heat-stroke-in-children.
  4. Jardine, D. S. (2007). Heat Illness and Heat Stroke. Pediatrics in Review, 28(7), 249–258. https://doi.org/10.1542/pir.28-7-249.
  5. Patel, J., et al. (2023). Critical illness aspects of heatstroke: A hot topic. Journal of Intensive Care Society, 24(2), 206-214. https://doi.org/10.1177/17511437221148922.
  6. Ramirez, O., Malyshev, Y., & Sahni, S. (2018). It’s Getting Hot in Here: A Rare Case of Heat Stroke in a Young Male. Cureus, 10(12), e3724. https://doi.org/10.7759/cureus.3724.

Hemostatis and Coagulation in the PICU04 Aug 202400:50:04
Introduction

Welcome to PICU Doc On Call, a podcast dedicated to current and aspiring pediatric intensivists. I'm Dr. Pradip Kamat from Children’s Healthcare of Atlanta/Emory University School of Medicine, and I’m Dr. Rahul Damania from Cleveland Clinic Children’s Hospital. We are two Pediatric ICU physicians passionate about medical education in the PICU. This podcast focuses on interesting PICU cases and their management in the acute care pediatric setting.

Episode Overview

In today’s episode, we are excited to welcome Dr. Karen Zimowski, Assistant Professor of Pediatrics at Emory University School of Medicine and a practicing pediatric hematologist at Children’s Healthcare of Atlanta at the Aflac Blood & Cancer Center. Dr. Zimowski specializes in pediatric bleeding and clotting disorders.

Case Presentation

A 16-year-old female with a complex medical history, including autoimmune thyroiditis and prior cerebral infarcts, was admitted to the PICU with acute chest pain and difficulty breathing. Despite being on low-dose aspirin, her oxygen saturation was 86% on room air. A CT angiography revealed a pulmonary embolism (PE) in the left lower lobe and signs of right heart strain. The patient was hemodynamically stable, and thrombolytic therapy was deferred in favor of anticoagulation. She was placed on BiPAP to improve her respiratory status. Her social history was negative for smoking, illicit drug use, or oral contraceptive use.

Key Case Points
  • Diagnosis: Pulmonary embolism (PE)
  • Hemodynamics: Stable with no right ventricular (RV) strain on echocardiogram
  • Management Focus: Anticoagulation and consultation with the hematology/thrombosis team

Expert Discussion with Dr. Karen ZimowskiRisk Factors and Epidemiology of VTE in Pediatrics
  • Pathophysiology: Venous thromboembolism (VTE) in children involves components of Virchow’s triad: stasis of blood flow, endothelial injury, and hypercoagulability.
  • Incidence: VTE is rare in the general pediatric population but increases significantly in hospitalized children.
  • Age Distribution: Bimodal peaks in infants and adolescents aged 15-17 years.
  • Risk Factors: Central venous lines, infections, congenital heart disease, cancer, and autoimmune disorders.

Clinical Manifestations of DVT
  • Symptoms: Swelling, pain, warmth, and skin discoloration in the affected extremity.
  • Specific Presentations:
  • SVC syndrome from superior vena cava thrombosis
  • Abdominal pain from portal vein thrombosis
  • Hematuria from renal vein thrombosis
  • Neurological symptoms from cerebral sinus venous thrombosis

Diagnostic Approach for DVT
  • Imaging:
  • Compression Doppler Ultrasonography: Primary method for diagnosing DVT in pediatric patients.
  • MR Venography (MRV) and CT Venography (CTV): Used for abdominal and cerebral sinus thrombosis.
  • Laboratory Studies:
  • D-dimer: Useful in adults; limited specificity in children.
  • Other Labs: Renal and liver function tests, CBC with differential, DIC panel.

Management of DVTAnticoagulation Strategies
  • Unfractionated Heparin (UFH):
  • Targets factors IIa and Xa; requires frequent monitoring.
  • Adverse events: Bleeding and thrombocytopenia.
  • Low Molecular Weight Heparin (LMWH):
  • More predictable pharmacokinetics than UFH.
  • Advantages include ease of administration and lower risk of HIT.
  • Vitamin K Antagonists (VKAs):
  • Used for long-term anticoagulation.
  • Requires regular INR monitoring.
  • Direct Oral Anticoagulants (DOACs):
  • Dabigatran, Rivaroxaban, and Apixaban used in pediatric VTE.
  • Advantages: No routine monitoring required, predictable effects.

Conclusion

In this episode, we discussed the intricacies of VTE diagnosis and management in pediatric patients. We thank Dr. Karen Zimowski for sharing her expertise on anticoagulation and hemostasis in the PICU. For more episodes and our Doc on Call management cards, visit picudoconcall.org.

Stay tuned for our next episode, and thank you for listening!

References
  1. Fuhrman & Zimmerman - Textbook of Pediatric Critical Care: Thrombosis in Pediatric Critical Care.
  2. American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism: Treatment of Pediatric Venous Thromboembolism.
  3. Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
  4. O’Brien, SH, Stanek JR, Witmer CM, Raffini L. The Continued Rise of Venous Thromboembolism Across US Children’s Hospitals. Pediatrics (2022).




PICU Doc on Call Shorts: Alveolar Gas Equation28 Apr 202400:20:06

Welcome to PICU Doc On Call, where Dr. Pradip Kamat from Children’s Healthcare of Atlanta/Emory University School of Medicine and Dr. Rahul Damania from Cleveland Clinic Children’s Hospital delve into the intricacies of Pediatric Intensive Care Medicine. In this special episode of PICU Doc on Call shorts, we dissect the Alveolar Gas Equation—a fundamental concept in respiratory physiology with significant clinical relevance.

Key Concepts Covered:

  • Alveolar Gas Equation Demystified: Dr. Rahul explains the Alveolar Gas Equation, which calculates the partial pressure of oxygen in the alveoli (PAO2). This equation, PAO2 = FiO2 (Patm - PH2O) - (PaCO2/R), is essential in understanding hypoxemia and the dynamics of gas exchange in the lungs.
  • Calculating PAO2: Using the Alveolar Gas Equation, the hosts demonstrate how to calculate PAO2 at sea level, emphasizing the influence of atmospheric pressure, fraction of inspired oxygen (FiO2), water vapor pressure, arterial carbon dioxide pressure (PaCO2), and respiratory quotient (R) on oxygenation.
  • A-a Gradient and Hypoxemia: The A-a gradient, derived from the Alveolar Gas Equation, is discussed in the context of hypoxemia evaluation. Understanding the causes of hypoxemia, including ventilation/perfusion (V/Q) mismatch, anatomical shunt, diffusion defects, and hypoventilation, is crucial for clinical diagnosis and management.
  • Clinical Scenarios and A-a Gradient Interpretation: Through a clinical scenario, the hosts elucidate how different conditions affect the A-a gradient and oxygenation, providing insights into respiratory pathophysiology and differential diagnosis.
  • Clinical Implications and Management Strategies: The hosts highlight the clinical significance of the Alveolar Gas Equation in assessing oxygenation status, diagnosing gas exchange abnormalities, and tailoring respiratory management strategies in the pediatric intensive care setting.

Key Takeaways:

  • Utility of the Alveolar Gas Equation: Understanding and applying the Alveolar Gas Equation is essential for evaluating oxygenation and diagnosing respiratory abnormalities.
  • Interpreting A-a Gradient: A normal A-a gradient suggests alveolar hypoventilation as the likely cause of hypoxemia, whereas elevated gradients indicate other underlying pathologies.
  • Clinical Relevance: Recognizing the clinical implications of the Alveolar Gas Equation aids in accurate diagnosis and optimal management of respiratory conditions in pediatric intensive care patients.

Conclusion:

Join Dr. Kamat and Dr. Damania as they unravel the complexities of the Alveolar Gas Equation, providing valuable insights into respiratory physiology and its clinical applications. Don’t forget to subscribe, share your feedback, and visit picudoconcall.org for more educational content and resources.

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter: Physiology of the respiratory system. Chapter 42. Khemani et al. Pages 470-481
  • Rogers textbook of Pediatric intensive care: Chapter 44. Respiratory physiology. Akong K et al. Pages 691-721
  • Respiratory Physiology for the Anesthesiologist. Bigatello L and Pesenti A, Anesthesiology 2019; 130: 1064-77




PICU Management of Malignant Hyperthermia14 Apr 202400:29:32

Welcome to PICU Doc On Call, A Podcast Dedicated to Current and Aspiring Intensivists.

  • Hosts:
  • Dr. Pradip Kamat: Children’s Healthcare of Atlanta/Emory University School of Medicine
  • Dr. Rahul Damania: Cleveland Clinic Children’s Hospital

Introduction:

  • Pediatric Intensive Care Unit (PICU) physicians passionate about medical education in the acute care pediatric setting
  • Episode focus: A case of a 23-month-old ex-28 week premie presenting with sudden high fever and rapidly rising ETCO2 during surgery

Case Presentation:

  • Presented by Dr. Rahul Damania
  • 23-month-old ex-28 week premie intubated during hernia repair surgery
  • Noticed rapidly rising ETCO2, unprovoked tachycardia, and elevated temperature
  • Transferred to PICU, exhibiting rigidity, clenched jaw, metabolic acidosis, and elevated lactate.
  • Consideration of Malignant Hyperthermia (MH) crisis

Key Points:

  • Elevated temperature, hypercapnia, metabolic acidosis, and unprovoked tachycardia raise concern for MH
  • Organized discussion on pathophysiology, clinical signs, symptoms, and management

Multiple Choice Question:

  • Diagnosis of MH crisis during scoliosis repair
  • Correct Answer: D) Sarcoplasmic reticulum
  • Dantrolene acts on the sarcoplasmic reticulum to inhibit calcium release, crucial in MH management

Clinical Presentation of MH Crisis:

  • Tachycardia, acidosis, muscle stiffness, and hyperthermia are hallmark features
  • Potential life-threatening complications underscore the urgency of recognition and treatment

Triggers and Pathophysiology of MH Crisis:

  • Triggered by inhalational agents and depolarizing neuromuscular blocking agents
  • Pathophysiology involves defective Ryanodine receptor leading to uncontrolled calcium release

Differential Diagnosis:

  • Includes sepsis, thyroid storm, pheochromocytoma, and neuroleptic malignant syndrome
  • Differentiation from similar conditions crucial for accurate management

Diagnostic Approach:

  • High clinical suspicion
  • Genetic testing (ryanodine receptor gene sequencing) and Caffeine Halothane Contracture Test (CHCT) for diagnosis
  • Immediate workup during crisis includes blood gas, lactate, CPK, CMP, and urine analysis

General Management Framework:

  • MH crisis is a medical emergency requiring rapid intervention
  • Dantrolene Na administration, supportive measures, and continuous monitoring in PICU
  • Utilization of Malignant Hyperthermia carts and involvement of specialized hotlines

Clinical Pearls and Pitfalls:

  • Early recognition is crucial.
  • Proper administration of Dantrolene Na without delay
  • Extended monitoring period in PICU to ensure stability

Conclusion:

  • Importance of recognizing and managing MH crisis
  • Feedback, subscription, and reviews encouraged
  • Website picudoconcall.org for additional resources

References:

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter
  • Malignant Hyperthermia Association of the United States
  • What is MH?
  • [Managing a crisis](https://www.mhaus.org/ healthcare-professionals/managing-a-crisis/)
  • Rosenbaum HK, Rosenberg H. UpToDate: Malignant hyperthermia: diagnosis and management of acute crisis.

Approach to Calcium Channel Blocker Overdose25 Feb 202400:26:01

Show Introduction

  • Welcome to PICU Doc On Call, a podcast dedicated to current and aspiring intensivists.
  • Hosted by Dr. Pradip Kamat and Dr. Rahul Damania

Case Presentation

  • A 14-year-old female with a history of depression and oppositional defiant disorder presents with dizziness, slurring speech, and is pale appearance.
  • The mother noticed symptoms of dizziness, stumbling, and sleepiness.
  • The patient had a prior suicide attempt.
  • Vital signs: HR 50 bpm, BP 75/40, GCS 10.
  • The initial workup reveals hyperglycemia, and she is stabilized and admitted to the PICU.

Key Aspects of Ingestion Work-up

  • History and physical exam are crucial.
  • Stratify acute or chronic ingestions.
  • Consider baseline medications and coingestants.
  • Perform initial screening examination to identify immediate measures for stabilization.

Diagnostic Studies

  • Pulse oximetry, continuous cardiac monitoring, ECG, capillary glucose measurement.
  • Serum acetaminophen, ASA levels
  • Consider extended toxicology screen.

Differentiating CCB vs. Beta-Blocker Overdose

  • ECG findings: PR interval prolongation and Bradydysrhythmia suggest CCB poisoning.
  • Hyperglycemia in non-diabetic patients may indicate CCB overdose

Approach to CCB Overdose

  • Initial resuscitation and stabilization
  • ABC approach
  • Consult Poison Control Center
  • Empiric use of glucagon, IV fluids, and vasopressors
  • Consideration of orogastric lavage and activated charcoal

Specific Medical Therapies

  • Vasopressors: norepinephrine/epinephrine infusion
  • Atropine for bradycardia
  • IV calcium salts to overcome cardiovascular effects
  • High-dose insulin and dextrose for myocardial function
  • Investigational therapies: methylene blue, lipid emulsion

Procedures

  • Transvenous pacemaker placement if needed
  • ECMO in refractory hypotension

Key Takeaways

  • Hypotension and bradycardia indicate life-threatening toxidromes.
  • Differential includes CCB, BB, digoxin, clonidine, and CNS depressants.
  • Stepwise approach includes close monitoring of ABCs and specific medical therapies.

Thank you for listening to PICU Doc On Call. We would love for you to share your feedback, subscribe, and review our podcast.

Visit picudoconcall.org for more information and resources.

Stay tuned for our next episode!

References

  • Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter 125 and 126.
  • St-Onge M et al. Treatment for calcium channel blocker poisoning: a systematic review.
  • DeRoos F. Calcium channel blockers. In: Goldfrank's Toxicologic Emergencies, 8th edition.

Acute Bronchiolitis in the PICU18 Feb 202400:29:57

Hosts:

  • Pradip Kamat, Children’s Healthcare of Atlanta/Emory University School of Medicine
  • Rahul Damania, Cleveland Clinic Children’s Hospital

Introduction

Today, we discuss the case of an 8-month-old infant with severe bronchospasm and abnormal blood gas. We'll delve into the epidemiology, pathophysiology, and evidence-based management of acute bronchiolitis.

Case Summary

An 8-month-old infant presented to the ER with decreased alertness following worsening work of breathing, preceded by URI symptoms. The infant was intubated and transferred to the PICU, testing positive for RSV. Initial blood gas showed 6.8/125/-4, and CXR revealed massive hyperinflation. Vitals: HR 180, BP 75/45, SPO2 92% on 100% FIO2, RR 12 (prior to intubation), now around 16 on the ventilator, afebrile.

Discussion Points

  • Etiology & Pathogenesis: Bronchiolitis is primarily caused by RSV, with other viruses and bacteria playing a role. RSV bronchiolitis is the most common cause of hospitalization in infants, particularly in winter months. Immuno-pathology involves an unbalanced immune response and can lead to various extra-pulmonary manifestations.
  • Diagnosis: Diagnosis is clinical, based on history and examination. Key signs include upper respiratory symptoms followed by lower respiratory distress. Blood gas, chest radiography, and viral testing are generally not recommended unless warranted by severe symptoms or clinical deterioration.
  • Management Framework: For patients requiring PICU admission, focus on oxygenation and hydration. High-flow therapy and nasal continuous positive airway pressure (CPAP) can be used. Hydration and feeding support are crucial. Antibiotics, steroids, and bronchodilators are generally not recommended. Mechanical ventilation and ECMO may be necessary in severe cases.
  • Immunoprophylaxis & Nosocomial Infection Prevention: Palivizumab and nirsevimab are used for RSV prevention in high-risk infants. Strict infection control measures, including hand hygiene and isolation, are essential to prevent nosocomial infections.

Conclusion

RSV bronchiolitis is a common and potentially severe respiratory illness in infants. Management focuses on supportive care, with a careful balance between oxygenation and hydration. Immunoprophylaxis and infection control are crucial in preventing the spread of the virus.

Thank you for listening to our episode on acute bronchiolitis. Please subscribe, share your feedback, and visit our website at picudoconcall.org for more resources. Stay tuned for our next episode!

References

Rogers - Textbook of Pediatric Critical Care Chapter 49: Pneumonia and Bronchiolitis. De Carvalho et al. page 797-823

Reference 1: Dalziel, Stuart R; Haskell, Libby; O'Brien, Sharon; Borland, Meredith L; Plint, Amy C; Babl, Franz E; Oakley, Ed. Bronchiolitis. The Lancet. , 2022, Vol.400(10349), p.392-406. DOI: 10.1016/S0140-6736(22)01016-9; PMID: 35785792

Reference 2: Schroeder AR, Destino LA, Ip W, Vukin E, Brooks R, Stoddard G, Coon ER. Day of Illness and Outcomes in Bronchiolitis Hospitalizations. Pediatrics. 2020 Nov;146(5):e20201537. doi: 10.1542/peds.2020-1537. PMID: 33093138.

The Modified Bohr Equation11 Feb 202400:18:09

Hosts:

  • Pradip Kamat, Children’s Healthcare of Atlanta/Emory University School of Medicine
  • Rahul Damania, Cleveland Clinic Children’s Hospital

Case Introduction:

  • 6-year-old patient admitted to PICU with severe pneumonia complicated by pediatric Acute Respiratory Distress Syndrome (pARDS).
  • Presented with respiratory distress, hypoxemia, and significant respiratory acidosis.
  • Required intubation and mechanical ventilation.
  • Despite initial interventions, condition remained precarious with persistent hypercapnia.

Physiology Concept: Dead Space

  • Defined as the volume of air that does not participate in gas exchange.
  • Consists of anatomic dead space (large airways) and physiologic dead space (alveoli).
  • Physiologic dead space reflects ventilation-perfusion mismatch.

Pathological Dead Space:

  • Occurs due to conditions disrupting pulmonary blood flow or ventilation.
  • Common in conditions like pulmonary embolism, severe pneumonia, or ARDS.

Clinical Implications:

  • Increased dead space fraction (DSF) in PARDS is a prognostic factor linked to severity and mortality.
  • Elevated DSF indicates worse lung injury and inefficient gas exchange.
  • DSF can be calculated using the formula: DSF = (PaCO2 – PetCO2) / PaCO2.

Practical Management:

  • Optimize Mechanical Ventilation
  • Enhance Perfusion
  • Consider Positioning (e.g., prone positioning)

Summary of Physiology Concepts:

  • Bohr equation for physiologic dead space.
  • Importance of lung-protective ventilation strategies.
  • Monitoring and trending dead space fraction.
  • Strategies to improve airway patency and mucociliary clearance.

Connect with us!

  • PICU Doc on Call provides concise explanations of critical concepts in pediatric intensive care.
  • Feedback, subscriptions, and reviews are encouraged.
  • Visit picudoconcall.org for episodes and Doc on Call infographics.
  • Hosted by Dr. Pradip Kamat and Dr. Rahul Damania.

Reference:

  • Yehya N, Bhalla AK, Thomas NJ, Khemani RG. Alveolar Dead Space Fraction Discriminates Mortality in Pediatric Acute Respiratory Distress Syndrome. Pediatr Crit Care Med. 2016 Feb;17(2):101-9. doi: 10.1097/PCC.0000000000000613. PMID: 26669646; PMCID: PMC4740261.

© My Podcast Data · Projet indépendant · Données issues d'Apple & Spotify